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Abstract 
 
 The transmission and prevalence of Hepatitis C Virus (HCV) among those who 
use injection drugs is a major public health issue. Injection drug use has been identified 
as the main cause of transmission for HCV in Canada. Street youth are at risk for 
acquiring HCV due to injection drug use that is often a consequence of living in a street 
environment. Presently, research on prevalence trends, characteristics, and associated 
behaviors for injection drug use and HCV in street youth, is limited. 
 The purposes of this study were to determine prevalence of injection drug use and 
HCV in Saskatoon street youth, to identify demographic or other factors that may 
contribute to street youth using injection drugs, and to identify risk factors and other 
characteristics of street youth associated with HCV. This study utilized data from Phase 
III of the Enhanced STD Surveillance in Canadian Street Youth Study by Health Canada 
for those participants recruited from Saskatoon, Canada. Between February and July 
2001, 186 Saskatoon street youth participants between the ages 14 and 24 years 
completed nurse-administered questionnaires and of these, 156 provided blood 
specimens. Analyses were conducted to compare population characteristics between 
street youth who have used injection drugs and those who had not. Similarly, population 
characteristics were analyzed among those street youth who were antibody-HCV positive 
and those that were antibody HCV negative. 
 In this study 32.3% of 186 participants had used injection drugs. Significant 
associations with injection drug use were found for older age (p = 0.01), having sexual 
partners that use injection drugs (p = 0.01), history of incarceration (p = 0.01), and 
history of living on the street (p = 0.02). Significant interactions were found for sex trade 
 iii 
work by gender (p < 0.01) and by age (p = 0.03), and for living on the street by age (p = 
0.02). A HCV prevalence rate of 9.3% of 156 participants was determined for Saskatoon 
street youth. Use of Ritalin by injection (p  = 0.04) and history of living on the street (p  = 
0.05) were found to be significant risk factors associated with HCV. The interaction of 
living on the street by gender was also significantly associated with HCV (p = 0.05). 
 The relationship identified between HCV and injection drug use in Saskatoon 
street youth was a history of living on the street. This link between could serve as a 
valuable marker for use of injection drugs and developing HCV infection in street youth. 
Nurses are encouraged to seek out street youth social networks to provide health care and 
messages of health promotion and disease prevention. Strategies that are culturally, 
socially, and developmentally appropriate are needed to keep these youth off the streets 
in the first place. 
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Chapter 1: Introduction 
1.1 Background of the Problem 
The transmission and prevalence of Hepatitis C Virus (HCV) among those who 
use injection drugs is a major public health concern. Injection drug use is a key mode of 
transmission of HCV, accounting for approximately 70% of all prevalent infections in 
Canada (Laboratory for Disease Control (LCDC), 1999).  National prevalence of HCV in 
the general public is estimated at 0.8% (Remis, 1998). Between 75 - 85% of people 
infected with HCV will progress to chronic infection. People with chronic infection 
remain a source of transmission for HCV and are at risk for chronic liver disease, 
cirrhosis, and liver cancer (LCDC, 1999). As a result of this infection, it is projected that 
in the next decade the number of liver failures will increase by 126%, and that the 
number of hepatocellular carcinomas will increase by 102% (Zou, Tepper, & El Saadany, 
2000).  Health and social systems may not be prepared to support these increases; thus 
surveillance, prevention, and control programs for HCV are urgently needed. 
It is estimated that 125,000 Canadians use injection drugs (Health Canada, 
2001a). People who use injection drugs are a key group in the persistence of HCV. This 
is due to a high HCV prevalence among populations that use injection drugs, the extreme 
risk of HCV infection due to highly efficient viral transmission that occurs with sharing 
of drug paraphernalia, and the initiation into drug-injecting behavior (Wiebe & Reimer, 
2000). 
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 Street youth have remained an under served population through out the HCV 
epidemic. This sub-population has unique characteristics, which place them at greater 
risk for acquiring the virus (Wiebe & Reimer, 2000). Street youth are often defined as 
“children and adolescents who become socially dislocated from their mainstream 
counterparts and who experience periodic or chronic homelessness” (Advisory 
Committee on Population Health (ACPH), 2001, p. 35). Homelessness is often 
predisposed by physical, emotional, and/or sexual abuse at home (ACPH, 2001). It is 
estimated that the street youth population ranges as high as 150,000 in Canada (ACPH, 
2001; DeMatteo et al., 1999). Contrary to popular belief, most street youth are not 
transient but rather come from the local community and surrounding area (Walters, 
1999). The use of illicit drugs, including use by injection, is particularly high among 
street youth (Roy et al., 1998). Sharing of drug paraphernalia and unsafe sexual practices 
has been noted among street youth who are involved in injection drug use (ACPH, 2001). 
However, research on prevalence trends, characteristics, and associated behavior for 
injection drug use and HCV in street youth, is limited (Anderson, Freese, & Pennbridge, 
1994; Rouget, Mah, Lang, & Joffres, 1994).  
In an effort to understand this marginalized population and fill the surveillance 
gap concerning street youth, Health Canada- Division of STD Prevention & Control, 
Bureau of HIV/AIDS, & STD, and TB Centre for Infectious Disease Prevention & 
Control, initiated a serial sentinel surveillance system in 1998 in multi sites across 
Canada (2001b). A main objective of this surveillance system was to determine the 
national prevalence rate and determinants of various STDs and risk behaviors in 
Canadian street youth (Health Canada, 2001b). As seen in Figure 1-1, Saskatoon has 
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participated in Phases II, III, and IV of this national, multi-center, cross-sectional 
surveillance study. Methodology regarding recruitment, inclusion criteria, and laboratory 
methods has remained consistent throughout the subsequent phases. Questionnaire 
modifications have varied between these phases, but have captured time trends. 
 
Year  
Phase 
 
Sites Included 
 
Health Canada 
Focus 
 
 
Study N 
 
1998 
 
I 
 
Vancouver, Ottawa, 
Halifax 
 
 
Feasibility 
study 
 
297 
 
1999 
 
II 
 
Vancouver, Edmonton, 
Saskatoon, Winnipeg, 
Toronto, Ottawa, Halifax 
 
Concentration 
on public 
exposure of 
results 
 
 
1733 
 
2001 
 
III 
 
Edmonton, Saskatoon, 
Winnipeg, Toronto, 
Ottawa, Montreal, Halifax 
 
Concentration 
on Chlamydia 
and sex trade 
modeling 
 
 
1475 
 
2003 
 
IV 
 
Yellowknife, Vancouver, 
Edmonton, Saskatoon, 
Winnipeg, Toronto, 
Ottawa, Halifax 
 
 
Increase sample 
size 
 
> 1700 
In progress 
 
2005 
 
V 
 
Unknown at this time 
 
Intervention 
planning 
 
 
Not determined  
 
Figure 1-1. Enhanced STD surveillance in Canadian street youth study: sites and focus. 
 
 
 
 
3 
1.2 Statement of the Research Problem 
 
Previous surveillance measures by Health Canada has identified Saskatoon as 
having high rates of HCV in street youth in comparison to other cities involved in the 
national study (Health Canada, 2003). Little is known about the characteristics of 
Saskatoon street youth that could contribute to this increased prevalence. In order to have 
effective local programming for HCV, it is necessary to understand the risks associated 
with injection drug use and HCV in the target population. To date, local data from the 
Enhanced STD Surveillance in Canadian Street Youth Phase III Study has not been 
examined and can provide the important information to determine prevalence of HCV, 
potential risk behaviors, and determinants of risk behaviors in the street youth population 
of Saskatoon. 
1.3 Relevance and Significance of Research 
 
 The information gleaned from this secondary analysis will raise awareness and 
understanding of HCV and injection drug use in Saskatoon street youth as a public health 
issue. This data is essential when considering whether or not street youth behaviors are a 
priority for prevention and control programs in Saskatoon. It is important to recognize 
that potential interventions need to be responsive to help describe the environment in 
which the unsafe behavior occurred (Wiebe & Reimer, 2000). The results of this analysis 
could have profound impact on the nature of future initiatives and intervention 
programming in community health nursing in Saskatoon. 
 
4 
 
 
 
 
Chapter 2: Literature Review 
 
2.1. Review of Relevant Research Literature 
The term street youth surfaced in the literature as early as 1991 (Wang et al.). 
Terms such as high-risk youth or youth at risk, homeless youth, throwaways or runaway 
youth are used interchangeably in the literature to describe street youth. It has been 
suggested that street involvement exists on a continuum. At one end of this continuum 
are curbsiders who engage in the street lifestyle to some extent, but engage in socially 
accepted behavior for the most part, circulating between home and the street.  At the 
other end are entrenched street youth that are involved in the dangers of street life and 
have no connection to home (Caputo, Weiler, & Anderson, 1997). Much of the literature 
about this population has focused on HIV/AIDS (Booth, Zhang, & Kwiatkowski, 1999; 
Clatts & Davis, 1999; DeMatteo, 1999; Kipke, Unger, Palmer, & Edgington, 1996; Roy 
et al., 2000, 2003; Walters, 1999; Weber, Boivin, Blais, Haley, & Roy, 2002). Other 
studies have looked at the following health outcomes with the street youth population 
including: sexually transmitted diseases (Anderson, Freese, &Pennbridge, 1994; Haley et 
al., 2002; Poulin et al., 2001; Van den Hoek, 1997), substance use (Ginzler, Cochran, 
Domenech- Rodriguez, Cauce, & Whitbeck, 2003; Green, Ennett, & Ringwalt, 1997; 
McMorris, Tyler, Whitbeck, & Hoyt, 2002),  injection drug use (Roy et al., 1998; Roy, 
Haley, Leclerc, Cedras & Boivin, 2002), Hepatitis A (Ochnio, Patrick, Ho, Talling, & 
Dobson, 2001; Roy et al., 2002), Hepatitis B (Beech, Myers, & Beech, 2003; Roy et al, 
1999),  depression (Ayerst, 1999; Smart, Adlaf, Walsh, & Zdanowicz, 1994; Smart & 
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Walsh, 1993), suicide and abuse (Kidd, 2003; Kidd & Kral, 2002; Molnar, Shade, Kral, 
Booth, & Watters, 1998) Despite similar modes of transmission in HIV and sexually 
transmitted diseases, little attention has been given to studies focusing on HCV in this 
population (Beech, Myers, & Beech, 2002). 
2.2. Review of Relevant Research 
 
As the risk of acquiring HCV in street youth exceeds that of HIV, a review was 
conducted to identify health literature related to transmission patterns and prevalence 
trends for HCV and injection drug use among the street youth population in Canada and 
the United States. Studies from the United States were reviewed because of similarity to 
Canadian health care accessibility, public health resources, and health-care seeking 
behaviors (van Dam, Dallabetta, & Piot, 1999). A summary of research studies 
examining the prevalence of injection drug use and HCV and predictors of HCV in Street 
Youth is presented in Table 2-1. 
This review revealed five studies specific to street youth in Canada. The first 
study, conducted in Ottawa in 1993, demonstrated a HCV prevalence of 4% in street 
youths less than 21 years of age (Slinger et al., 1999). Other studies conducted in 
Montreal in 1995 - 1996 and in Regina in 2000, found HCV prevalence rates of 12.6% 
(Roy et al. 2001) and 19.2% (Regina Health District, n.d.) in youth aged 14 - 24 years. 
Studies conducted in Vancouver from 1996 - 1999 revealed a prevalence of HCV 
infection of 46% in youth aged 13 - 24 (Miller et al., 2002), and 81.6% in injection drug 
users 15 - 58 years of age (Patrick et al., 2001). In the Canadian general population, 
prevalence of HCV infection is 0.8% (Zou, Tepper, & El Saadany, 2000). 
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Table 2-1 
Summary of Research Examining the Prevalence of Injection Drug Use and HCV and 
Predictors of HCV in Street Youth 
Prevalence Authors Location Sample IDU HCV 
Predictors of 
HCV 
Beech, Myers, & 
Beech (2002 
Southwest city, 
USA 
- N = 150 
- 10 – 23 years 
Not 
reported 
22% for 
HBV or 
HCV 
Lifetime crack use, 
sexual preference, ↑ of 
sexual partners, ↑ age, 
gender (not specified) 
Diaz et al. (2001) New York City, 
USA 
- Lower East Side: 
N=357 
- Harlem: N=200 
- 18 – 29 years 
100% Lower East 
Side: 42% 
Harlem: 
52% 
IDU > 3 years, IDU with 
known HCV person, 
sharing cotton 
Hahn, Page-Shafer, 
Lum, Ochoa, & 
Moss (2001) 
San Francisco, 
USA 
-N = 308 
- < 30 years 
100% 45 ↑ age, ↑ years injecting, 
↑ years in the city, first 
injected by sex partner, 
daily IDU, borrowed 
syringe, improper 
bleaching of borrowed 
needle, snorted/smoked 
drugs in prior year, 
injected by someone else 
in prior month 
Regina Health 
District (n.d.) 
Regina, Canada - 14 – 24 years 
N=52 
- > 24 years: 
N=202 
- Overall: 
100% 19.2% 
 
53.5% 
46.5% 
Older age, longer history 
of IDU, tattooed, 
borrowed needles/gear  
while incarcerated, 
sharing equipment with 
HCV positive peer, ever 
attempted suicide, ever 
abused 
Lifson & Halcom 
(2001) 
Minneapolis, 
USA 
- N=201 
- 15 – 22 years 
15% 25% self-
reporting 
Not determined 
Miller et al. (2002) Vancouver, 
Canada 
- N = 232 
- 13 – 24 years 
100% 46% Aboriginal status, older 
age, greater # of years 
with IDU, recent 
incarceration, sex trade 
work > 100 sexual 
partners, previous 
sexually transmitted 
disease, IDU>1 x per day 
of heroin/ cocaine 
/speedball 
Patrick et al. (2001) Vancouver, 
Canada 
- N=1345 
- 15 – 58 years 
100% 81.6% Female gender, cocaine 
use, IDU daily, frequent 
attendance at a needle 
exchange program 
Roy et al. (2001) Montreal, 
Canada 
- N=437 
- 14 – 25 years 
45.8% 12.6% IDU, age 18+, crack / 
cocaine use, more than 1 
tattoo 
Slinger et al. (1999) Ottawa, Canada - N=100 
- < 21 years 
17% 4% Not determined 
Thorpe, Ouellet, 
Levy, Williams, & 
Monterroso (2000) 
Ottawa, Canada 
Chicago, USA 
- N=698 
- 18 – 30 years 
- All IDU 
100% 27% Age, duration & 
frequency of IDU, heavy 
crack smoking, IDU in a 
shooting gallery, syringe 
sharing 
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Canadian HCV prevalence is comparable to that in the United States with similar 
populations. Four studies from the United States were relevant for review. A study 
conducted in Chicago from 1997 - 1999 found a HCV prevalence rate of 27% among 
injection drug users aged 18 - 30 years (Thorpe, Ouellet, Levy, Williams, & Monterroso, 
2000). Similarly, in San Francisco during the same time period, HCV prevalence was 
45% in injection drug users less than 30 years of age (Hahn, Page-Shafer, Lum, Ochoa, & 
Moss, 2001). Diaz et al. (2001) found HCV prevalence of 42% in its lower east side of 
New York and a prevalence of 52% in Harlem in groups of injection drug users 18-29 
years (Diaz et al., 2001). These rates are high in comparison to a study conducted in 
Boston with an unselected population of adolescents showing a HCV prevalence of 0.1% 
(Jonas, Robertson, & Middleman, 1997). 
From the review of the literature, street youth populations with HCV are likely to 
be older, use injection drugs, have undergone tattooing, and be female. The majority of 
study populations were entirely injection drug users. There are limited findings in studies 
for other factors. Variables of sex trade work, incarceration history, and body piercing 
were inconsistently assessed within the studies reviewed. For example, Miller et al. 2003 
and Patrick et al, 2001 did not address the practices of tattooing and body piercing within 
their studies. Injection drug use has been consistently identified as the factor most 
strongly associated with HCV infection in this literature review. Social determinants 
associated with this high-risk behavior were not specifically explored in any of the 
studies.  A study among street youth in Toronto, not specific to HCV, found drug use 
(including that by injection) to be symptomatic of family dysfunction and a hazardous 
street environment (Adalf, Zdanowicz, & Smart, 1996). 
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Social determinants that include poverty, homelessness, lack of education, family 
dysfunction, parental substance abuse, mental health problems, and child abuse have been 
identified as predisposing people for injecting drugs (ACPHA, 2001; Schoener, Hopper, 
& Pierre, 2002). Although, these findings are reflective of general adult populations, they 
may not be reflective of street youth populations. It is further noted that social 
determinants of injection drug use are similar to the antecedents of homelessness or youth 
moving to the streets. These antecedents include family dysfunction, physical, emotional, 
and sexual abuse, poor self-image, negative school experiences (Caputo, Weiler, & 
Anderson, 1997), and the failure of multiple societal structures (Higgitt, Wingert, 
Ristock, Brown, Ballantyne, Caett et al., 2003). Many of these determinants and 
antecedents are available for analysis in this study. 
2.2.1. Consistencies and Inconsistencies between Studies. 
The studies reviewed generally used convenience sampling and were similar in 
their purpose, design, instruments, and data collection, but findings in relation to 
prevalence and associated risk behaviors differed between samples. No qualitative studies 
could be located which examined HCV. Study populations tend to be comprised of male, 
Caucasian, and older adult injection drug users. There is very little information on the 
nature of injection drug use and HCV in street youth and females in particular. All studies 
analyzed in this review used a questionnaire/survey instrument asking for socio-
demographic characteristics, sexual behavior, drug use practices, and other similar risk 
behaviors. Only one study did not include the serum-testing component (Lifson & 
Halcon, 2001) in the data collection, but instead asked participants if they had been 
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tested. In the data by Beech, Myers & Beech (2002) no distinction is made between HCV 
and Hepatitis B Virus rates. 
Studies consistently reported injection drug use as significantly associated with 
HCV infection. This may be partly explained by the risk behaviors of the cohorts studied 
who were predominately injection drug users as compared with street youth overall. 
Findings suggest that the two main drug risk categories in relation to HCV are cocaine 
injection and crack/cocaine smokers. Cocaine use involves particular risk as cocaine is 
metabolized very quickly in the body (Wiebe & Reiner, 2000).  Thus, people who inject 
cocaine require frequent injections to maintain the effects of the drug thus increasing the 
problems associated with obtaining clean drug paraphernalia (McAmmond & Associates, 
1997). 
All studies had self-reported behavioral data which may be prone to response 
bias. Although HCV prevalence reported in these studies are comparable with adult 
studies of HCV, the sampling methods used was snowball sampling which may limit 
generalizablity of findings to all street youth. 
Study sites are reflective of street youth living in large urban centers. Canadian 
studies were from Montreal, Ottawa, Regina, and Vancouver- indicating there is very 
little Canadian information on the extent and nature of HCV among street youth in other 
parts of the country. The samples in the Regina and Vancouver studies were all injection 
drug users rather than specifically street youth.  
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2.3. Conceptual Framework of the Relationship between Injection Drug Use  
 
and Hepatitis C Virus 
 
 Demographics, high-risk behaviors, and determinants of high-risk behaviors in 
Saskatoon’s street youth population were examined in order to understand the 
relationship between injection drug use and HCV from a local perspective.  The 
conceptual framework, the Relationship between Injection Drug Use and HCV, as seen in 
Figure 2-1, was developed to organize characteristics of street youth for data analysis of 
the Saskatoon sample. The framework developed was a synthesis of the researcher’s 
clinical experience and variables identified in the literature review. This overall 
framework is based on the model, Sexual Health Practices of Homeless Adolescents, 
developed by Rew (2001). Based on Rew's work, three main focuses are identified for 
this study of street youth, and injection drug use/HCV. These focuses were: population 
characteristics (demographics, high-risk behaviors, and culture of homelessness), 
mediating variables (cognitive-perceptual and behavioral factors), and street youth 
outcomes. The demographic category included variables of age, gender, and ethnicity. 
The high-risk behaviors category of tattooing, body piercing, sex trade history, sexual 
behavior, and substance use are documented associated risks for HCV.  The category, 
culture of homelessness, includes education, income, family dysfunction, abuse, and 
interaction with social support systems, mental health status, and a history of living on 
the street. 
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Figure 2-1.  Conceptual framework of the relationship between injection drug use and 
HCV in street youth. 
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Although separate from this analysis, the framework does identify cognitive-
perceptual and behavioral factors (mediating variables) that may be important to examine 
when planning behavior change and risk reduction interventions for the outcomes of 
injection drug use or HCV (Rew, Fouladi, & Yockey, 2002). These factors, or modifying 
variables include: knowledge of HCV, perceived social support, perceived risk of HCV, 
self efficacy to utilize harm reduction strategies, communication, help-seeking behavior, 
and coping strategies. 
Population characteristics and mediating variables provided valuable insight into 
the identification of the outcomes of injection drug use and HCV status. The conceptual 
framework is a useful guide for evaluating risk factors associated with Saskatoon’s street 
youth population. Information about many of the population characteristics noted to be 
important in street youth populations, outlined by this model, could be obtained from 
Phase III of the Health Canada database. Mediating variables were not available from this 
database but would provide useful assessments in future research.  Injection drug use 
behaviors within the street youth culture may be viewed as those practices that reflect the 
complex interactions of population characteristics and cognitive-perceptual and 
behavioral factors that may or may not lead to HCV status. An understanding of the 
injection drug use and HCV relationship is a prerequisite when developing interventions 
for this vulnerable population. 
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2.4. Formulation of Research Questions 
 
 Based on a review of the literature and available information from Phase III of the 
Enhanced STD Surveillance in Canadian Street Youth Study, the following questions 
were examined: 
1. What is the prevalence of injection drug use and Hepatitis C Virus in Saskatoon 
street youth? 
Rationale: Limited information is available on the prevalence of HCV and injection drug 
use in the street youth population. Research on prevalence is needed to understand the 
scope of the problem in Saskatoon so that the need for intervention may be determined. 
Further research could confirm trends in the development of HCV infection in newer and 
younger injection drug users, as HCV prevalence has reached saturation levels among 
middle-aged, long-term injectors (Thorpe et al, 2000). 
2. What characteristics are associated with injection drug use in Saskatoon street 
youth? 
Rationale: A number of individual and social factors often associated with street survival 
propel youth towards high-risk behaviors including injection drug use. An understanding 
of these factors is urgently needed to prevent these youth from initiating injection drugs 
and to identify new users (Wiebe & Reimer, 2000). 
3. What characteristics are associated with Hepatitis C Virus in Saskatoon street 
youth? 
Rationale: Injection drug use is currently the most important route of transmission of 
HCV yet little is known about HCV transmission in Saskatoon street youth. The relative 
contribution of transmission through other routes involving minor or unapparent exposure 
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to blood is inconclusive from the literature, particularly for street youth. Prevention and 
control programs of HCV need to be tailored to local patterns of behavior and 
characteristics of populations at risk. 
2.5 Definition of Research Variables 
 
The following operational definitions were used in this study as designated by the 
Enhanced STD Surveillance in Canadian Street Youth Phase III Study (Health Canada, 
2001b). 
2.5.1 Definition Of Independent Variable  
1. Street Youth criteria for participation: 
• 14 to 24 years of age AND 
• able to understand spoken French or English AND 
• able to understand and recognize the purpose of the study AND 
• IN ADDITION, in the last six months, 
• have run away from home or other place of residence for three 
days or more OR 
• been thrown out of home for three days or more OR 
• been without a fixed address for three days or more 
2.5.2. Definitions of Dependent Variables  
1. Hepatitis C Virus (HCV): 
 Serum with antibodies having positive or indeterminate results using a 
third generation recombinant immunoblot assay (HCV 3.0 RIBA). 
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2. Injection Drug Use (IDU): 
An affirmative response to the question: “In your life, have you ever injected or 
been injected at least once with drugs in your veins or under your skin (make a fix or to 
shoot yourself up)?” (See Appendix A, Question 23a). 
2.5.3. Definitions of Attribute Variables 
1. Age:  
The date of the interview subtracted by the date of birth of the participant 
resulting in years within the range of 14 and 24. 
2. Ethnicity: 
An affirmative response to the question: “What ethnic origin do you consider 
yourself to be?” from the following responses: First Nations, Canadian, Hispanic, 
African, Chinese, Caribbean, Middle East (See Appendix A, Question 3). 
3. Sex trade work: 
  An affirmative response that a sexual act was done in exchange for either food, 
money, shelter, drugs, and /or material possessions (See Appendix A, Question 30). 
4. Sexual abuse: 
The affirmative response to having unwanted sex (oral, vaginal, or anal) with a 
person of authority whether force was involved or not (See Appendix A, Question 25). 
The definition excluded date rape, consensual sex at an early age, or unwanted sex while 
living on the street (Health Canada, 2001b). 
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5. Depression: 
Feeling down, depressed, or hopeless (See Appendix A, Question 34h). Those 
youth that responded to the question as ‘strongly agree’ or ‘agree’ were categorized as 
being depressed. 
6. Attempted suicide:  
The response of ‘strongly agree’ or ‘agree’ to the question “In the past I have 
attempted to commit suicide” (See Appendix A, Question 35a). 
2.6. Assumptions of Study 
 The following assumptions can be applied to the proposed study: 
1. This is a street youth population of adolescents in Saskatoon and therefore 
findings cannot be generalized to general adolescent populations. 
2. The findings are based on street youth found in urban settings and cannot be 
generalized to rural settings. 
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Chapter 3: Methodology 
 
3.1 Description of Phase III Primary Study 
3.1.1 Research Design and Procedure 
 An algorithm used for the Saskatoon street youth study is seen in Appendix B. 
Street youth who had consented to participate in the study were administered a gender 
specific questionnaire (see Appendix A). This questionnaire preceded the collection of 
serum for HCV. The questionnaire consisted of questions on demographics, income and 
level of education, family history, sexual health, lifestyle behaviors, and knowledge of 
sexually transmitted diseases as mentioned previously. The questionnaire was 
administered based on gender. Questionnaire information solicited was identical for 
males and females except for question 40a referring to pregnancy which was asked of 
females. This variable was not used in the current analysis. A female version of the 
Enhanced STD Surveillance in Canadian Street Youth Phase III Questionnaire is seen in 
Appendix A. 
Participants in the study were asked to provide a urine sample and two tubes of 
blood from a single needle-stick poke. Urine was obtained from those consenting youth 
to test for chlamydia and gonorrhea.  Consenting youth had their blood stored and tested 
for Hepatitis B Virus (HBV), syphilis, Human Immunodeficiency Virus (HIV), Herpes 
Simplex Virus-1 (HSV - 1), Herpes Simplex - 2 (HSV - 2), Human T Lymphotropic 
Virus (HTLV) and HCV. 
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Those participants who did not agree to give a blood sample were only asked to 
participate in the initial questionnaire. Counselling and referrals were done as required, at 
the conclusion of the study procedure. Participants were paid an honorarium of $10.00 
for participating in the questionnaire and received an additional $10.00 honorarium if 
they returned for their test results. If youth did return for their results, follow up was 
initiated as indicated in Appendix B. At no time was any information that could identify 
study subjects given to Health Canada. 
  All questionnaires were forwarded to the Division of STD Prevention and 
Control-Health Canada prior to October 2001. The data was entered and cleaned in 
Ottawa by Health Canada staff using Microsoft Excel. An electronic data set of 
Saskatoon’s Phase III questionnaire data was returned to Saskatoon in January 2003. 
3.1.2 Identification of Research Sample 
 
 Health Canada used snowball-sampling methods to recruit Saskatoon street youth 
as study participants. Youth were asked to inform others within their social networks that 
the study was being conducted. By using word of mouth as advertisement for the study, 
recruitment reached youth who may have not intended to participate. Those youth who 
adopt false identities or who may be on the run from city to city, had an opportunity to 
hear of the study. Participation in the study was voluntary. Eligibility criteria were 
designated by Health Canada (See operational definition of street youth on p.15). Youth 
who did not meet these criteria were excluded from the study (2001b).  
3.1.3 Sample Setting 
Recruitment was carried out through drop-in centres during day and evening 
hours. Youth who are on the streets may not necessarily visit the same drop-in centers, so 
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at least three drop-in centers were approached to participate in the study. See Appendix C 
for locations of agencies for study recruitment. 
3.2 Ethical Considerations 
 
3.2.1 Ethical Approval of Phase III Primary Study 
 Health Canada required that the Saskatoon site obtain local ethics approval prior 
to data collection. Ethics approval was obtained on September 7, 1999 from the 
University of Saskatchewan Advisory Committee on Ethics in Human Experimentation 
and expired October 1, 2001 as seen in Appendix D. 
 A research nurse informed study participants about the procedure and purpose of 
the study in simple, clear language. The consent used in this study is seen in Appendix E. 
Each participant received written consent and both the study nurse and the participant 
signed two copies of the consent form. One copy was retained with the questionnaire and 
one copy was given to the participant. At the end of the initial interview, each participant 
was given a card with their unique identifier, name and number of the study coordinator, 
and date to return for their results at their interview site. 
 Participants were informed that they could withdraw from the study at any time. 
They were further informed that refusing to participate in the study would not jeopardize 
use of the drop-in center or other adjunct services at the time of the individual interview 
or any time in the future. They were also informed that providing laboratory specimens 
was optional. 
 All participants were assigned an identification number that was used on all data 
collection forms. Names linked to identification and consents for participation were 
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stored in a locked filing cabinet at Idylwyld Health Centre- Public Health Services. These 
forms were only accessible by the research team. 
3.2.2 Ethics Approval for Secondary Analysis 
 Prior to commencement of this secondary analysis, a research proposal was 
submitted to the researcher’s Thesis Committee at the College of Nursing, University of 
Saskatchewan and the University of Saskatchewan Behavioral Research Ethics Board for 
approval. Ethical approval to conduct the present study was received November 18, 2003. 
A copy of the approval letter from the University of Saskatchewan Behavioral Research 
Ethics Board is seen in Appendix F. Approval was also obtained from Public Health 
Services- Saskatoon Health Region for use of their data. The researcher has received 
electronic confirmation of approval in support of this analysis from Health Canada 
(S.Shields, personal communication, March 2003; see Appendix G). 
3.3 Measurement Methods 
 
 The measurement instruments used in this secondary analysis included the data 
set from a nurse-administered questionnaire and one from the laboratory specimen of 
HCV confirmation. 
3.3.1 Questionnaire 
An electronic data set of Saskatoon’s questionnaire data was made available to the 
researcher by Public Health Services, Saskatoon Health Region. The data set received by 
the researcher excluded those results of participants from local detention facilities. Data 
collected from these detention facilities had not been cleaned and ready for analysis as 
not all sites in the overall study collected data from detention settings. 
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Readability and comprehension of the questionnaire was assessed in 1998 in the 
pilot phase of the overall Canadian study. Validity of data responses were ascertained 
through the calculation of kappa statistics by Health Canada (2001b). The data collection 
instrument used for this analysis was a modified version of the questionnaire used in the 
pilot phase. Kappa statistics and exact modifications to the questionnaire made by Health 
Canada, were not made available to the researcher. 
In order to establish reliability in administering the questionnaire, the study 
recruited public health nurses experienced in working with street-involved youth as 
research nurses. Nurses participated in a teleconference prior to data collection to 
establish consistency in protocol with the questionnaire documentation and laboratory 
specimen collection. 
3.3.2 Laboratory Testing for HCV 
 In the primary study, youth had their blood stored and tested for antibodies to 
HCV. Initial HCV screening was conducted with an Ortho HCV 3.0 EIA test. Positive 
samples were confirmed with a third generation recombinant immunoblot assay (HCV 
3.0 RIBA). In a low prevalence population, the RIBA assay has high sensitivity (negative 
RIBA results mean that the EIA was a false-positive) and high specificity (high positive 
predictive value, i.e., HCV RNA is detected in > ~ 80% of RIBA positive samples). If an 
indeterminate result was obtained on the RIBA assay, then polymerase chain reaction 
(PCR) testing was used to differentiate between acute versus chronic infection (Health 
Canada, 2001b). A second data set linking Saskatoon’s study identification number with 
a positive HCV result was requested of Health Canada by the researcher for the purpose 
of this analysis. This second data set was received in September 2003. 
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3.4 Sample Size 
  
 A main focus of this study was to determine the association between HCV and 
certain risk behaviors. As available sample size was predetermined, the adequacy of that 
sample size for this secondary analysis was tested using the following formula 
(Schlesselman, 1982): 
 n = 2pq(zα + z β)2/(p1-pο)2      (3.1) 
where: p = p1 + pο)/2 
 q = 1-p 
 p1 = pοR/[1 + pο(R-1)] 
and where: 
 pο = estimates exposure rate among the comparison group 
 R = relative risk 
 α = level of significance used to detect a difference (risk of a false positive) 
 β = probability of not detecting a significant difference when there really is a 
difference 
 1- β = the degree of certainty that if the difference is present, it would be 
detected 
 In order to calculate sample size, the risk behavior chosen for HCV was tattooing. 
The Canadian study by Roy et al. (2001) was used to evaluate this exposure because it 
was similar in age of participants and the eligibility criteria for participation. Roy et al. 
found the estimated rate among the non-HCV group for tattooing was 0.528. Therefore, 
pο  = 0.528. A relative risk of 2.0 was considered as supporting a clinically meaningful 
relationship between risk exposure and HCV (Kleinbaum, Kupper, Muller &Nizam, 
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1998). Both an α = 0.05 and statistical power (1- β) of 0.80 were considered as 
reasonable levels of significance and power to use (Kleinbaum et al., 1998). Therefore, if 
β = 0.20, then zβ = 0.842. If α = 0.05, then zα  = 1.96 (Kleinbaum et al). Thus, 
substituting in equation 3.1: 
  2[(0.6095)(0.3905)][1.96 + 0.842]²/(0.691 – 0.528)² = 140.2 
an estimated sample of 140 street youth participants is required to identify a two-fold 
increase in risk of HCV associated with exposures to tattooing, if such a risk existed. The 
sample size available in this secondary analysis was 186 street youth and therefore was 
determined to be adequate for the purposes of this analysis. 
3.5 Data Management and Analysis 
 
 Questionnaire data received from Public Health Services- Saskatoon Health 
Region was merged with the laboratory tests for HCV using Microsoft Excel. Data was 
then imported from Excel using the Statistical Package for Social Sciences (SPSS) Data 
Entry Program for IBM PC microcomputers and verified using random variable case 
summaries. SPSS Base 11.0 was used to recode missing data and analyze the data. 
Categorical variables (demographic data and general health characteristics of street 
youth) were analyzed descriptively using frequency distributions, percentages, cross 
tabulations, and Chi square tests. The Chi square test was also used to examine 
associations between categorical variables and the dependent variables, which include 
injection drug use and HCV status. The independent sample t-test was used to compare 
means for continuous data in relation to these dependent variables. 
 Risk factors found to be significant for injection drug use and HCV positive 
status, at the univariate level, were examined using mulitivariate logistic regression 
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analysis.  Variables with a univariate significance level of p ≤ 0.25 were considered for 
entry into the multivariate model. The use of a more traditional level of significance, such 
as 0.05, often fails to identify variables known to be of importance. This larger 
significance level allowed suspected variables to become candidates for inclusion in the 
multivariate model (Hosmer & Lemeshow, 2000). Variables of significance were tested 
for interaction by both gender and age prior to model building. Multiple logistic 
regressions, using the Enter method, were then used to determine which variables were 
independently associated with injection drug use and HCV positive status. The Enter 
method allows for the simultaneous examination of clinically relevant and statistically 
significant variables (Hosmer & Lemeshow, 2000). The level of significance for retention 
in the final model was set at α = 0.05.  
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Chapter 4: Results 
 
 These results contain analysis of Saskatoon data from the Enhanced STD 
Surveillance in Canada Street Youth Phase III Study conducted between February and 
July, 2001 by the Division of Sexual Health Promotion and STD Prevention and Control 
Centre for Infectious Disease Prevention and Control, Health Canada. The conceptual 
framework of the study, as seen in Figure 2-1 was used to assist in naming population 
characteristics of street youth in the data analysis of the Saskatoon sample. Figure 4-1 
shows the distribution of participants used in this analysis. 
4.1 Sample Size 
A total of 186 street youth participants were recruited and interviewed for this 
analysis. From these participants, 83.9% (N = 156) had HCV blood testing. Of the 
remaining study participants who were not tested for HCV (n = 30), 27 participants did 
not consent to that component of the study, and three participants were unable to provide 
a sufficient amount of blood to perform the serologic test.  
4.2 Population Characteristics of Saskatoon Street Youth 
 Population characteristics of street youth were examined overall and by gender. 
4.2.1 Demographics  
 Table 4-1 highlights demographic characteristics of study participants. Data 
analyses identified 59.7 % (n = 111) youth were male and 40.3% (n = 75) youth were 
female demonstrating a gender split (male to female) of 1.48 :  1. 
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 Saskatoon Street Youth Participants 
(N = 186) 
1. Population Characteristics 
(n = 186) 
2. Street Youth Outcomes 
(n = 186) 
Demographics 
(n = 186) 
High Risk Behaviors 
 (n = 186) 
Culture of Homelessness  
(n = 186) 
IDU Status 
(n = 186) 
IDU User Characteristics 
(n = 61) 
HCV Status 
(n = 156) 
HCV Screening not 
performed 
(n = 30) 
IDU Characteristics
(n = 55) 
 
Figure 4-1. Breakdown of major analysis used in study of Saskatoon street youth. 
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Table 4-1 
Demographic Characteristics by Gender in Saskatoon Street Youth Participants  
(N = 186) 
 
 
Variable Male 
n = 111 
Female 
n = 75 
Total 
N = 186 
Mean age (SD) 
 
17.8 (2.59) 18.0 (2.79) 17.9 (2.67)
Ethnicity 
     Aboriginal 
     Non-Aboriginal 
94 (84.7) 
17 (15.3)
 
58 (77.3) 
17 (22.7) 
152 (81.7) 
34 (18.3)
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As predetermined by eligibility criteria, study participants were 14 to 24 years of 
age.  The age proportion of street youth in the 14 to 17 age bracket was 50.5 % (n = 94) 
while those youth in the 18 to 24 age bracket were 49.5 % (n = 92). There was no 
difference by gender for mean age of subjects. 
 An overwhelming 81.7% (n = 152) of all participants self-identified themselves as 
being Aboriginal. Ethnic categories were not read out to the street youth so the 
possibilities of discrimination from predefined ethnic categories were eliminated. 
However, the interviewer could classify participants based on their most prominent 
response. The gender breakdown for Aboriginal street youth was 61.8% male and 38.2% 
female demonstrating a male to female ratio of 1.6 : 1. 
4.2.2 High Risk Behaviors 
 High risk behaviors examined included tattooing, sexual behavior, sex trade, and 
substance abuse. 
4.2.2.1 Tattoo and body piercing. 
Gender differences for tattooing and body piercing are presented in Figure 4-2. 
Forty-eight percent (48.4%) of participants reported having at least one tattoo and 65.1% 
reported having ear and/or body piercing. Females were more likely to have ear and/or 
body piercing  (χ² = 12.35, df = 1; p < 0.001). 
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4.2.2.2 Sexual behavior. 
The degree of sexual activity varied widely amongst participants. Overall, 91.9% 
(n = 171) of all participants reported having willing sexual activities (vaginal, anal, or 
oral) with a mean 19.6 ± 56.49 of lifetime (regular, casual, and sex trade) partners. Male 
participants reported a mean of 12.4 ± 13.78 lifetime partners while female participants 
reported 30.3 ± 86.61 such partners (t = 2.142, df = 76.54, p = 0.08). 
Of all male participants, 93.7% (n = 104) report being sexually active.  All 
respondents had one or more female sexual partners and two respondents identified one 
or more male partners. Male participants reported 68% condom use with their most recent 
sexual experience with a female partner, and 100% condom use with their most recent 
male partner.  
Of all female participants, 89.3% (n = 67) reported being sexually active with one 
or more male sex partners and 12 females or 17.9% of females identified as having one or 
more female sex partners. Female participants report 43.3% condom use with their most 
recent sexual experience with a male partner, and 0% barrier use with their most recent 
female partner. 
4.2.2.3 Sex trade. 
Overall, 28% (n = 52) of participants traded sex at least once in their lifetime. 
Money was identified as the most common item received after having traded sex. The 
average age for first time in the sex trade was 15.89 years for males (range = 12-20 
years), and 14.73 years (range = 10-21 years) for females.  More females (63.5%) 
reported trading sex than males (36.5%), (χ² = 16.06, df = 1; p <0.001). Risk behaviors 
that were significantly associated with reporting sex trade were sexual abuse (χ² = 22.76, 
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df = 1; p < 0.001) and previous use of injection drugs (χ2 = 14.51, df = 1; p < 0.001). 
Compared to those not involved in the sex trade, subjects involved in sex trade practices 
were more likely to be HCV positive (46.7%), (χ² = 2.84, df = 1; p = 0.09). 
Characteristics and risk behaviors of participants involved in sex trade activities by 
gender are presented in Table 4-2. 
4.2.2.4 Substance use. 
Substance use was common among this group of street involved youth. The use of 
alcohol, tobacco, and non-injection drugs (excluding prescription drugs) by gender is 
presented in Figure 4-3. Overall, 40.9% (n = 76) of street youth reported use of alcohol 
one or more times a week. Males (45.9%) were more likely to be alcohol users than their 
female counterparts (33.3%), (χ2 = 2.95, df = 1; p = 0.09). 
Those street youth who reported smoking cigarettes occasionally (n = 25) or 
everyday (n = 149) were categorized as cigarette smokers. Overall, 93.5% (n = 174) of 
participants reported smoking cigarettes with no significant difference by gender. 
Overall, 96.8% (n = 180) of all street youth reported using non-injection drugs at least 
once in their lifetime. There is no significant difference by gender for using non-injection 
drugs. Marijuana was the most common non-injection drug used, with 80.6% (n = 150) of 
participants reporting this use in the three months prior to the interview. The non-
injection use of diverted prescription drugs was reported by only two participants; one 
youth reported using valium, the other reported using codeine. 
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Table 4-2 
Characteristics and Behaviors Associated with Participation in Sex Trade Activities by 
Gender in Saskatoon Street Youth Participants (n  = 52) 
 
Variable Male 
n = 19 
Female 
n = 33 
Total 
N = 52 
Aboriginal ethnicity 
     No 
     Yes 
 
5 (26.3) 
14 (73.7)
 
8 (24.2) 
25 (75.8) 
13 (25.0) 
39 (75.0)
Sexual abuse history¹ 
     No 
     Yes 
 
16 (84.2) 
3 (15.8)
 
14 (42.4) 
19 (57.6) 
30 (57.7) 
22 (42.3)
Use of injection drugs² 
     No 
     Yes 
 
16 (84.2) 
3 (15.8)
 
8 (24.2) 
25 (75.8) 
24 (46.2) 
28 (53.8)
HCV positive³ 
     No 
     Yes 
10 (100) 
0 (0.0)
 
26 (78.8) 
7 (21.2) 
45 (86.5) 
7 (13.5)
¹p < 0.01; ²p < 0.001; ³p < 0.05 
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4.2.3 Culture of Homelessness 
 4.2.3.1 Education. 
Most street youth had a secondary level of education or were enrolled in 
secondary school as seen in Table 4-3. Overall, 48.9% of street youth reported they were 
not currently attending school with no significance by gender. The main reason given by 
youth for not attending school (33.3%) was that they had either dropped out or had been 
kicked out of school. Three participants indicated they no longer attended school because 
they had completed their grade twelve or equivalent. 
4.2.3.2 Income. 
Participants were asked to report what their principal source of income was in the 
three months prior to the interview. For 33.3% of youth, money from their family was 
their main source of income. Another 31.7% indicated they received money from social 
welfare and 9.1% obtained money from stealing, robbery, or scams. 
 4.2.3.3 Leaving home. 
Participants that reported no longer living with a parent or caregiver (n = 103), or 
that reported living with them for part of a week but not everyday (n = 3) were 
categorized as not living with their parents/caregivers. More than half of the participants 
(57%) reported no longer living with their parents/caregivers of which 39% had not done 
so for more than one year. Youth reported arguing with parents as the main reason for 
leaving home. Youth who reported arguing as the main reason for leaving home were 
further questioned as to the topics of argument between themselves and their parents. Of 
this group, 33.3% reported arguing over rules being set and broken and 22.2% identified 
their own drug or alcohol use as the most common topics for argument. 
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Table 4-3 
Education Status by Gender in Saskatoon Street Youth Participants (N = 186) 
 
 
Variable Male 
n = 111 
Female 
n = 75 
Total 
N = 186 
Education Level 
     Primary school 
     Secondary school 
     Post-secondary 
 
19 (17.1) 
90 (81.1) 
2 (1.8)
 
11 (14.7) 
64 (85.3) 
0 (0.0) 
30 (16.1) 
154 (82.8) 
2 (1.1)
Currently attending school 
Not attending school 
52 (46.8) 
59 (53.2)
43 (57.3) 
32 (42.7) 
95 (51.5) 
91 (48.9)
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4.2.3.4 Abuse. 
When participants were asked if some form of abuse was a reason for not living 
with their parents, 15.6% (n = 29) responded that it was. Of those who reported abuse, 
41.3% (n = 12) reported physical abuse and 51.7% (n = 15) reported emotional abuse. 
Females were more likely to report both physical abuse (χ² = 6.41, df = 1; p = 0.01) and 
emotional abuse (χ² = 4.71, df = 1; p = 0.03) than males. 
Street youth were asked if they have ever experienced sexual abuse. Overall, 
19.9% (n = 37) of street youth reported being sexually abused. Approximately 89% of the 
self-identified Aboriginal street youth reported sexual abuse versus 10.8% of non-
Aboriginal street youth. Aboriginal females represented the largest proportion of sexually 
abused street youth in this sub-population (χ² = 3.98, df = 1, p = 0.05) compared to 
males. See Table 4-4 for sexual abuse by gender in street youth participants. 
 4.2.3.5 Family dysfunction. 
Twenty percent (20.4%) of street youth reported that their family was homeless or 
living in a shelter at some point while they were growing up. It is noted that two youth 
refused to answer this question. Overall, 72% of participants reported that their parents 
were separated or divorced while they were growing up. More female street youth 
(82.7%) were likely to have separated or divorced parents than males (64.9%) (χ² = 7.04, 
df = 1; p = 0.008). 
Participants were questioned as to the injection drug use history of both their 
father and mother. Overall, 13.4% of street youth identified that their father used 
injection drugs while 15.1% had mothers who used injection drugs in the past. Parental 
substance use was not associated with participant’s gender. 
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Table 4-4 
Sexual Abuse by Gender in Saskatoon Street Youth Participants (n = 37) 
 
Variables Male 
N=9
Female 
N=28 
Total 
N=37
Aboriginal ethnicity 
 
8 (88.9) 25 (89.3) 33 (89.2)
Non-Aboriginal ethnicity 
 
1 (11.1) 3 (10.7) 4 (10.8)
Non-regular use of alcohol 
Regular use of alcohol  
 
5 (55.6) 
4 (44.4)
22 (78.6) 
6 (21.4) 
27 (73.0) 
10 (27.0)
Never used non-injection drugs 
Used non-injection drugs  
 
0 (0) 
9 (100)
2 (7.1) 
26 (92.9) 
2 (5.5) 
35 (94.6)
Never used injection drugs 
Used Injection drugs¹ 
 
8 (88.0) 
1 (11.1)
10 (35.7) 
18 (64.3) 
18 (48.6) 
19 (51.4)
HCV Negative status 
HCV Positive status 
8 (88.9) 
1 (11.1)
22 (78.6) 
6 (21.4) 
30 (81.1) 
7 (18.9)
¹p < 0.01 
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In order to gain understanding into the home environment of street youth, 
participants were asked questions regarding their parent’s interaction and behavior while 
they were growing up. The responses to the questions asked are seen by gender in Figure 
4-4. Overall, the following percentages were reported by study participants in reference 
to parental activities and behaviors in their home environment: 75.3% reported verbal 
abuse, 53.2% reported hitting or assault, 50.5% reported being arrested or in jail or 
prison, and 51.1% reported throwing or breaking things in anger. Females were more 
likely to have parents hit or assault each other (χ² = 5.860, df = 1; p = 0.02) and have 
parents that throw or break things in anger (χ² = 10.224, df = 1; p = 0.001). 
 4.2.3.6 Contact with social support systems. 
Youth are often involved with social support systems before leaving their 
permanent home. Figure 4-5 provides the number of youth who reported having 
interactions with social support systems. Overall, the following percentages were 
reported by participants with reference to their interaction with social supports: 67.7% 
had a social worker, 60.8% had been placed in foster care, and 38.7% had been in at least 
one group home. Females were more likely than males to have a social worker (74.7% 
versus 63.1%); (χ² = 2.56, df = 1, p = 0.097), and have been placed in foster care (70.7% 
versus 54.1%), (χ² = 5.18, df = 1, p = 0.02). 
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participants (N = 186) 
4.2.3.7 Contact with the justice system. 
Youth were questioned if they ever had a probation or parole officer. Overall, 
56.5% of participants identified they had a probation or parole officer at some point in 
their life. In addition, 70.4% of participants reported having ever been to a detention 
facility, youth detention centre, prison, or jail, overnight or longer. Males were 
significantly more likely to have a probation or parole officer (63.1%), (χ² = 4.90, df = 1, 
p = 0.03) and significantly more likely to have been in detention or jail (80.2%), (χ² = 
12.57, df = 1, p < 0.001) as seen in Figure 4-6. 
 4.2.3.8 Mental health status. 
When participants were asked about history of depression 31.7% of participants 
reported being depressed. More females (40%) than males (26.1%) reported current 
depression (χ² = 3.98, df = 1, p = 0.05). Participants were also questioned if they had ever 
attempted to commit suicide.  Overall, 36.6% of participants responded as having 
attempted to commit suicide. Females were significantly more likely to attempt to 
commit suicide than males (χ² = 26.48, df = 1, p < 0.001). This data is not presented. 
 4.2.3.9 Homelessness. 
When participants were asked if they had ever lived or continue to live on the 
streets, 33.3% indicated that they had. Having lived on the streets was not significant by 
gender. In a separate line of questioning, 40.9% (n = 76) of street youth identified that 
they spent greater than 40 hours a week hanging out on the street. Almost half of this 
group reported this behavior did not change with Saskatchewan weather. More males 
(47.7%) were likely to hang out on the street than their female counterparts (30.7%) (χ² = 
5.40, df = 1; p = 0.02).
42 
010
20
30
40
50
60
70
80
90
P
e
r
c
e
n
t
a
g
e
Probation/Parole
Justice System
n = 8
n = 70 
n = 105 
n = 35
 
  Figure 4-6. Contact with the justice system by gender in Saskatoon street
43 Detention/J
9
n = 42 
 youth partiail
Male (n = 111)
Female (n = 75)
Overall (N = 186)
 
n = 131
cipants (N = 186). 
Street youth were also questioned as to where they would sleep the night they 
participated in the interview. Most youth (57%) would sleep at home with 
parents/siblings/relatives (n = 106), 10.8% (n = 20) would sleep at friends' homes, 15.1% 
(n = 28) would sleep in their own place. Of the remaining 17.2%, 14.5% (n = 27) 
reported having to stay in a shelter, hotel, group home, or safe house, and 2.7% (n = 5) 
stated they didn’t know where they were going to sleep that night. 
4.3 Results in Relation to Research Questions 
4.3.1 Research Question 1 
What is the prevalence of injection drug use and Hepatitis C Virus in Saskatoon street 
youth? 
Overall, 32.8% (n = 61) of 186 street youth reported having ever used injection 
drugs in their lifetime. Overall, 23.1% (n = 43) reported they had injected drugs more 
than once in their life and 9.7% (n = 18) reported using injection drugs once in their 
lifetime. There was a trend for more females than males to have used injection drugs at 
some point in their lives (χ² = 2.96, df = 1, p = 0.09). See Figure 4-7a and Figure 4-7b for 
overall injection drug use findings and prevalence of injection drug use by age and 
gender. There were no significant associations for injection drug use by age and gender.
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46 Male
Female
There were 156 youth who provided blood specimens for HCV screening. 
Overall, thirteen youth were found to be HCV antibody positive and two youth were 
HCV antibody indeterminate for an overall prevalence of 9.6% (n = 15). Indeterminate 
results are to be resolved by PCR testing (Health Canada, 2001b), however the results of 
any further testing have not been received by Health Canada. Of those that tested 
positive, only 26.7% (n = 4) youth were aware of this infection at the time of the 
interview. Figure 4-8 presents prevalence of HCV by age and gender, with no significant 
associations identified. 
The prevalence of HCV was 20% in those participants that had underwent HCV 
screening and identified as having used injection drugs (n = 11/55). Females were more 
likely to have HCV at an earlier age than males.  No males between 14 and 16, or 23 and 
24 years had HCV infection. Likewise, no females between the ages of 21 and 22 years 
had HCV infection. 
 Further analysis was conducted comparing those participants who had provided 
serum for HCV screening with those participants who had not provided serum. 
Demographic and injection drug use behavior by participants who underwent HCV 
screening and those who did not is presented in Table 4-5.  No significant associations 
were found between the two groups. 
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 Table 4-5 
Demographic and Injection Drug Use Behavior by Hepatitis C Virus Screening (n = 156) 
∗ 1 cell (16.7) has expected count less than 5. The minimum expected count is 2.90. 
Variable n (%) No HCV Screening  
(n = 30) 
HCV Screening 
(n = 156) 
Age mean (SD) 17.3 (2.69) 18.0 (2.65)
Gender  
     Male 
     Female  
 
18 (60.0) 
12 (40.0) 
93 (59.6) 
63 (40.4)
Aboriginal ethnicity 
     No 
     Yes 
 
5 (16.7) 
25 (83.3) 
29 (18.6) 
127 (81.4)
Use of injection drugs ∗ 
     Never 
     Once 
     More than once 
 
24 (80.0) 
5 (16.7) 
1 (3.3) 
101 (64.7) 
38 (24.4) 
17 (10.9)
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4.3.2 Research Question 2 
What characteristics are associated with injection drug use in Saskatoon street youth? 
 Participants who reported having used injection drugs (n = 61) included both 
current and past users. Characteristics by gender are seen in Table 4-6. The mean age of 
first injection drug use in this group of injection drug users was 15.6 ± 2.41 years.  
Females were significantly younger (mean age = 15.6 ± 2.28 years) than their male 
counterparts (mean age = 16.2 ± 2.40 years) in their age of initiation into this risk 
behavior (t = 2.10, df = 59, p = 0.04). Of particular concern is that 65.6% of all 
participants that reported ever using injection drugs did so at age of less than 16 years. 
Females were injecting drugs for a longer period of time averaging 4.5 years, or on 
average 1.2 years longer than their male counterparts (t = -1.770, df = 59, p = 0.08). 
 Street youth were questioned about their use of clean equipment when injecting 
drugs in order to determine the degree of sharing behavior in this population. Participants 
that responded as using clean equipment ‘some of the time’ or ‘most of the time’ were 
categorized as having used unclean equipment. The questionnaire did not differentiate 
between the types of gear used in the sharing behavior. More females used unclean drug 
paraphernalia versus males (χ² = 0.560, df = 1, p = 0.508 FET), however this was not 
significant. Overall, very few participants (16.4%) reported using unclean equipment 
when injecting drugs. Among those currently injecting drugs that report injecting on a 
weekly basis, the mean number of injections per week was 24.4 (± 63.49) or 
approximately 3.5 injections per day. In the three months prior to the interview, Ritalin 
was the drug most frequently injected (44.3%), followed by morphine (39.3%), and 
cocaine (27.9%). 
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Table 4-6 
Injection Drug Use Characteristics by Gender in Saskatoon Street Youth Participants    
(n = 61) 
 
Variable Male 
n = 31  
Female 
n = 30  
Total 
N = 61 
Mean age of first injection (SD)¹ 
 
16.2 (2.40) 15.0 (2.28) 15.6 (2.41)
     By age category 
     <14 years 
     14 to 16 years 
     17-18 years 
     >18 years    
 
4 (12.9) 
15 (48.4) 
6 (19.4) 
6 (19.4)
 
9 (30.0) 
12 (40.0) 
8 (26.7) 
1  (3.3) 
 
13 (21.3) 
27 (44.3) 
14 (23.0) 
7 (11.5)
Mean frequency of injections/week (SD) 
 
12.9 (11.45) 36.2 (89.0) 24.4 (63.49)
 
    Ritalin by injection 
 
    Morphine by injection 
 
    Cocaine by injection 
 
14 (45.2) 
11 (35.5) 
7 (22.6)
 
13 (43.3) 
 
13 (43.3) 
 
10 (33.3) 
 
27 (44.3) 
 
24 (39.3) 
 
17 (27.9)
Mean years of injecting(SD)² 
 
3.3 (2.27) 4.5 (2.89) 3.9 (2.64)
    By year category ² 
      ≤ 2 years 
     3 years 
     4-5 years 
     ≥ 6 years 
 
13 (41.9) 
5 (16.1) 
8 (25.8) 
5 (16.1)
 
11 (36.7) 
4 (13.3) 
2  (6.7) 
13 (43.3) 
 
24 (39.3) 
9 (14.8) 
10 (16.4) 
18 (29.5)
Used unclean equipment 4 (12.9) 6 (20.0) 10 (16.4)
¹p < 0.05; ²p < 0.10 
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The relationships between injection drug use and demographic characteristics and 
high-risk behaviors were further examined. Table 4-7 presents findings for these 
population characteristics by injection drug use status.  
 Females were more likely to use injection drugs than males (χ² = 2.96, df = 1, p = 
0.09). The majority of all street youth identified themselves as being Aboriginal; however 
ethnicity was not found to be significantly associated with injection drug use. 
 The mean number of lifetime sexual partners for the sample was 19.65 ± 56.49 
partners (median = 7.0, range = 0- 515 partners). The mean number of lifetime partners 
was significantly higher for those youth that had used injection drugs (mean = 39.2 ± 
92.58 partners) than those youth that had never used injection drugs (mean = 10.1 ± 18.26 
partners). Those participants who identified as having a sexual partner that used injection 
drugs in the three months prior to the interview, were more likely to use injection drugs 
themselves. The abuse of other substances did not differ between those youth who used 
and didn’t use injection drugs. 
 The relationships among culture of homelessness variables and injection drug use 
were also examined as seen in Table 4-8. Participants who were not attending school (χ² 
= 16.90, df = 1, p < 0.001) and not living with their parent/caregiver on a daily basis (χ² = 
8.49, df = 1, p = 0.004) were more likely to report injection drug use. 
A history of sexual abuse was significantly associated with injection drug use (χ² 
= 7.216, df = 1, p < 0.01), as was physical abuse use (χ² = 6.677, df = 1, p = 0.02  FET), 
and emotional abuse use (χ² = 8.493, df = 1, p < 0.01). A history of working in the sex 
trade was also significantly associated with injection drug use (χ² = 14.51, df = 1, p < 
0.001). 
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Table 4-7 
Demographics and High Risk Behaviors by Injection Drug Use Status in Saskatoon Street 
Youth Participants (N = 186) 
 
 
Variable IDU Ever IDU Never Total
Age mean(SD)¹ 
 
19.4 (2.78) 17.2 (2.28) 17.9 (2.67)
Sex n(%)² 
     Male 
     Female 
 
31 (50.8) 
30 (49.2)
 
80 (64.0) 
45 (36.0) 
111 (59.7) 
75 (40.3)
Aboriginal ethnicity 
     No 
     Yes 
 
8 (13.1) 
53 (86.9)
 
26 (20.8) 
99 (79.2) 
34 (18.3) 
152 (81.7)
Mean lifetime partners³ 
      
39.2 (92.58) 10.1 (18.26) 19.7 (56.49)
Lifetime sexual partners¹ 
     ≤ 7 partners  
     ≥ 8 partners  
       
19 (31.1) 
42 (68.9)
 
78 (62.4) 
47 (37.6) 
97 (52.2) 
89 (47.8)
Sexual partner with IDU¹ 
     No  
     Yes 
 
46 (75.4) 
15 (24.6)
 
 
121(98.6) 
4 (3.2) 
167 (89.8) 
19 (10.2)
Sex trade history¹ 
    No 
    Yes 
 
33 (54.1) 
28 (45.9)
 
101 (80.8) 
24 (19.2) 
134 (72.0) 
52 (28.0)
Non-injection drug use 
     No 
     Yes 
 
1 (1.6) 
60 (98.4)
 
 
5 (4.0) 
120 (96.0) 
6 (3.2) 
180 (96.8)
Regular use of alcohol 
     No 
     Yes 
 
33 (54.1) 
28 (45.9)
 
77 (61.6) 
48 (38.4) 
110 (59.1) 
76 (40.9)
Smoke cigarettes² 
     No 
     Yes 
1 (1.6) 
60 (98.4)
 
11 (8.8) 
114 (91.2) 
12 (6.5) 
174 (93.5)
¹p < 0.001; ²р < 0.10; ³ p < 0.05  
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Table 4-8 
Culture of Homelessness Characteristics by Injection Drug Use Status in Saskatoon 
Street Youth Participants (N = 186) 
 
 
Variable IDU Ever IDU Never Total
Attending school¹ 
     No 
     Yes 
43 (70.5)
18 (29.5)
 
48 (38.4) 
77 (61.6) 
91 (48.9) 
95 (51.1)
Main income of social 
welfare 
     No 
     Yes 
 
40 (65.6)
21 (34.4)
 
 
87 (69.6) 
38 (30.4) 
127 (68.3) 
59 (31.7)
Father IDU 
     No 
     Yes 
 
53 (86.9)
8 (13.1)
 
108 (86.4) 
17 (13.6) 
161 (86.6) 
25 (13.4)
Mother IDU  
     No 
     Yes 
 
50 (82.0)
11 (18.0)
 
108 (86.4) 
17 (13.6) 
158 (84.9) 
28 (15.1)
Parents 
separated/divorced 
     No 
     Yes 
 
19 (31.1)
42 (68.9)
 
33 (26.4) 
92 (73.6) 
52 (28.0) 
134 (72.0)
Sexual abuse history² 
    No 
    Yes 
 
42 (68.9)
19 (31.1)
 
107 (85.6) 
18 (14.4) 
149 (80.1) 
37 (19.9)
Emotional abuse history² 
     No 
     Yes  
 
51 (83.6)
10 (16.4)
 
120 (96.0) 
5 (4.0) 
171 (91.9) 
15 (8.1)
Physical abuse history² 
     No  
     Yes 
 
53 (86.9)
8 (13.1)
 
121 (96.8) 
4 (3.2) 
174 (93.5) 
12 (6.5)
Living with parents2 
        No 
     Yes 
 
44 (72.1)
17 (27.9)
 
62 (49.6) 
63 (50.4) 
106 (57.0) 
80 (43.0)
¹p < 0.001; ²p < 0.01; ³p < 0.05 
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Table 4-8 (continued) 
Culture of Homelessness Characteristics by Injection Drug Use Status in Saskatoon 
Street Youth Participants (N = 186) 
 
Variable IDU Ever IDU Never Total
Ever in detention or jail¹ 
     No 
     Yes 
 
5 (8.2)
56 (91.8)
 
50 (40.0) 
75 (60.0) 
55 (29.6) 
131 (70.4)
Ever had social worker² 
     No 
     Yes 
 
11 (18.0)
50 (82.0)
 
49 (39.2) 
76 (60.8) 
60 (32.3) 
126 (67.7)
Ever been in foster care 
     No 
     Yes 
 
22 (36.1)
39 (63.9)
 
51 (40.8) 
74 (59.2) 
73 (39.2) 
113 (60.8)
Ever been in group home³ 
     No 
     Yes 
 
31 (50.8)
30 (49.2)
 
83 (66.4) 
42 (33.6) 
114 (61.3) 
72 (38.7)
Depressed  
     No 
     Yes 
37 (60.7)
24 (39.3)
 
90 (72.0) 
35 (28.0) 
127 (68.3) 
59 (31.7)
Attempted suicide²  
    No 
    Yes 
 
29 (47.5)
32 (52.5)
 
89 (71.2) 
36 (28.8) 
118 (63.4) 
68 (36.6)
Ever lived on streets² 
     No 
     Yes 
 
33 (54.1)
28 (45.9)
 
91 (72.8) 
34 (27.2) 
124 (66.7) 
62 (33.3)
Hang out on streets³ 
(>40 hrs/week) 
     No 
     Yes 
 
35 (57.4)
26 (42.6)
 
 
75 (60.0) 
50 (40.0) 
110 (59.1) 
76 (40.9)
¹p < 0.001; ²p < 0.01; ³p < 0.05 
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Street youth participants whose parents had separated or divorced and who 
identified as having a mother who used injection drugs, or as having a father who had 
used injection drugs, were examined as determinants of family dysfunction. Seventy-two 
percent (72%) of youth reported that their parents had separated or divorced. More street 
youth reported having a mother (15.1%) than a father (13.4%) who used injection drugs, 
however neither variable were associated with injection use. 
 Street youth participant’s contact with social support systems and the law were 
also examined as these systems are often indicators to homelessness and street 
involvement. Ever having a social worker (χ² = 8.405, df = 1, p = 0.004), ever living in a 
group home (χ² = 4.194, df = 1, p = 0.041), or ever having been in detention center or jail 
overnight or longer (χ² = 19.910, df = 1, p < 0.001), were significantly associated with 
injection drug use. Participants who reported a history of attempted suicide were also 
likely to use injection drugs (χ² = 9.89, df = 1, p = 0.002). Depression in this group was 
also examined, but was not found to be significant. A history of living on the street was 
significantly associated with injection drug use. (χ² = 6.45, df = 1, p = 0.01). 
4.3.2.1 Summary of findings of population characteristics with injection drug use. 
 Separate analyses were conducted to examine associations between population 
characteristics and injection drug use as the outcome. This analysis compared injection 
drug use between street youth participants who have ever injected drugs with those youth 
who have never used injection drugs as the reference. A number of characteristics were 
found to be significant for injection drug use status at the univariate level. A summary of 
these variables with odds ratios and 95% confidence intervals (CI) are presented in Table 
4-9. The continuous variable, lifetime sexual partners, was recoded into categories  
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Table 4-9 
Univariate OR (95% CI) Results for Variables Associated with Injection Drug Use 
(p < 0.25) 
 
Variable OR 95% CI 
Gender 
 
1.72 0.92 - 3.20 
Aboriginal ethnicity 
 
1.74 0.74 - 4.11 
Currently smoke cigarettes 
 
5.79 0.73 - 45.92 
Lifetime sexual partners 
 
3.67 1.91 - 7.04 
Sexual partners that use injection drugs(past 3 
months) 
 
9.86 3.11 - 31.23 
Sex trade history 
 
3.57 1.82 - 6.99 
Sexual abuse history 
 
2.69 1.29 - 5.62 
Physical abuse history 
 
4.57 1.32 - 15.82 
Emotional abuse history 
 
4.71 1.53 - 14.46 
Feeling depressed/ hopeless 
 
1.67 0.88 - 3.18 
Attempted suicide 
 
2.73 1.45 - 5.14 
Not attending school 
 
0.26 0.14 - 0.50 
Not living with parents/caregiver (daily) 
 
0.38 0.20 - 0.74 
Ever in detention or jail 
 
7.47 2.80 - 19.94 
Ever had a social worker 
 
2.93 1.39 - 6.17 
Ever been in a group home 
 
1.91 1.02 - 3.57 
Ever lived on streets 2.27 1.20 - 4.30 
 
57 
because of the large standard deviations reported. This recoding resulted in the variable, 
lifetime sexual partners, having two categories: participants that have less than seven 
sexual partners and participants that have more than seven sexual partners. Strong 
associations between injection drug use, as observed by the p-value (p  ≤ 0.01) were 
found for age, lifetime sexual partners, having sexual partners that use injection drugs, a 
history with the sex trade, a history of abuse (sexual, physical, and emotional), having 
attempted suicide, not attending school, not living with a parent or caregiver, a history of 
incarceration, having had a social worker, and a history of living on the street.  
4.3.2.2 Multivariate analysis. 
Model building began with selection of clinically important variables and 
statistically significant variables associated with injection drug use from the univariate 
logistic analysis, based on p-values ≤ 0.25. Variables chosen for the full model included: 
age, gender, Aboriginal ethnicity, history of lifetime sexual partners, having sexual 
partners that used injection drugs, history of sex trade work, abuse history (sexual, 
physical, and emotional), depression, having attempted suicide, not attending school, not 
living with parents/caregiver on a daily basis, having had a social worker, having lived in 
a group home, incarceration history, and having lived on the streets. Variables to be 
included in the model were then tested for interaction with age and gender, using logistic 
regression. Nine interaction terms with independent variables and age and gender were 
identified as significant as seen in Table 4-10: sexual abuse history by age and by gender, 
sex trade history by age and by gender, being in a group home by age and by gender, 
having lived on the street by age and by gender, and not attending school by gender.  
These interaction terms were entered into the model as well. 
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Table 4-10 
Logistic Regression OR (95% CI) Results for Interaction Variables Associated with 
Injection Drug Use (p < 0.25) 
 
Variable OR 95% CI 
Interaction of sexual abuse and gender 
 
17.45 1.67 - 182.96 
Interaction of sex trade and gender 
 
53.96 8.96 - 324.96 
Interaction of sexual abuse and age 
 
0.79 0.59 - 1.05 
Interaction of sex trade and age 
 
0.72 0.55 - 0.95 
Interaction of not attending school and gender 
 
0.39 0.10 - 1.59 
Interaction of being in a group home and gender  
 
2.74 0.75 - 10.03 
Interaction of being in a group home and age 
 
1.33 0.97 - 1.84 
Interaction of living on street and gender 
 
0.61 0.39 - 0.98 
Interaction of living on street and age 1.26 0.92 - 1.73 
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The full model can be seen in Table 4-11. The significance for retention of 
variables in the model was set at p = 0.05. The full model was reduced by removing non-
significant clinical variables one at a time. The variables, Aboriginal ethnicity, categories 
of lifetime sexual partners, history of sexual and physical abuse, depression, not attending 
school, not living with parents/caregiver on a daily basis, having had a social worker, 
having lived in a group home, sexual abuse interactions, group home interactions, not 
attending school by gender, and living on the street by gender were removed from the full 
model. Any further exclusion of variables from the reduced model resulted in a change of 
ß value greater than 20% having moderate effects on all the other variables included in 
the reduced model. 
Therefore, 11of the 26 variables included in the full model were chosen to fit the 
final model as seen in Table 4-12. Significant positive associations in the final model 
continued for seven variables which included: age, having sexual partners that use 
injection drugs, incarceration history, having lived on the streets, sex trade history by 
gender and by age, and having lived on the street by age. Model building analysis can be 
seen in Appendix H. 
4.3.2.3 Model diagnostics. 
Several approaches were taken to look at the fit of the final model. The full and 
final models were compared using the likelihood ratio test. The full model differed 
somewhat from the final model (χ² = 14.697, df =15, p > 0.05), but not significantly. 
Thus, the reduced model appeared to have good fit (with the full model). 
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Table 4-11 
Full Model using Logistic Regression comparing the Injection Drug Using Group to the 
Never Used Injection Drug Group 
 
Variable ß SE OR (95%CI) p-value
Age 
 
0.292 0.195 1.34 (0.92, 1.96) 0.13
Female (ref: male) 
  
-0.143 1.149 0.87 (0.91, 8.25) 0.90
Aboriginal (ref: non-Aboriginal) 
 
0.642 0.747 1.90 (0.44, 8.22) 0.39
Eight or more lifetime sexual 
partners (ref: ≤ 7 sexual partners) 
 
0.340 0.563 1.41 (0.47, 4.24) 0.55
Sexual partners that use injection 
drugs (ref: sexual partners do not 
use injection drugs) 
 
2.578 0.975 13.18 (1.95, 88.99) 0.01
Sex trade work history (ref: no 
history of sex trade work) 
 
4.944 5.135 140.29 
 (0.01, 3296259.00) 
0.34
Sexual abuse history 
(ref: never sexually abused) 
 
-1.151 5.998 0.32 (0.00, 40349.50) 0.85
Emotional abuse history) 
(ref: never emotionally abused) 
 
3.829 1.486 46.02 (2.50, 847.25) 0.01
Physical abuse history 
(ref: never physically abused 
 
-2.039 1.722 0.13 (0.00, 3.80) 0.24
Feeling depressed/hopeless 
(ref: not feeling depressed/hopeless) 
 
0.447 0.576 1.564 (0.51, 4.84) 0.44
Have attempted suicide 
(ref: never attempted suicide) 
 
0.874 0.533 2.40 (0.84, 6.81) 0.10
Not attending school 
(ref: currently attending school) 
 
-0.838 1.644 0.432 (0.2, 10.85) 0.61
Not living with parent/caregiver 
(daily)(ref: daily living with 
parents/caregiver) 
0.801 0.644 2.23 (0.63, 7.87) 0.21
 
χ² = 114.933, df = 26, ά = 0.05 
-2 log likelihood = 120.440 
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Table 4-11 (continued) 
Full Model using Logistic Regression comparing the Injection Drug Using Group to the 
Never Used Injection Drug Group 
 
χ² = 114.933, df = 26, ά = 0.05 
Variable ß SE OR (95%CI) p-value
Have had a social worker  
(ref: never had a social worker) 
 
0.180 0.607 1.20 (0.37, 3.93) 0.77
Ever lived in a group home 
(ref: never lived in a group home) 
 
-7.184 6.021 0.00(0.00, 101.23) 0.23
History of incarceration 
(ref: no history of incarceration) 
 
1.826 0.886 6.21 (1.09, 35.24) 0.04
Ever lived on the streets 
 
-19.972 7.673 0.00 (0.00, 0.01) 0.01
Sex trade work history by gender 
 
3.647 1.407 38.37 (2.44, 604.47) 0.01
Sex trade work history by age 
 
-0.565 0.255 0.57 (0.35, 0.94) 0.03
Sexual abuse history by gender 
 
1.666 1.598 5.29 (0.23, 121.32) 0.30
Sexual abuse history by age 
 
-0.094 0.250 0.91 (0.56, 1.49) 0.71
Not attending school by gender 
 
-0.018 1.089 0.98 (0.12, 8.29) 0.99
Group home history by gender 
 
0.216 1.244 1.24 (0.11, 14.21) 0.86
Group home history by age 
 
0.320 0.286 1.38 (0.79, 2.41) 0.26
Living on the street history by 
gender 
 
1.337 1.470 3.81 (0.21, 67.89) 0.36
Living on the street history by age 0.984 0.354 2.68 (1.34, 5.36) 0.01
-2 log likelihood = 120.440 
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Table 4-12 
Final Model using Logistic Regression comparing the Injection Drug Using Group to the 
Never Used Injection Drug Group 
 
χ² = 100.236, df = 11, ά = 0.05 
Variable ß SE OR (95%CI) p-value
Age 
 
0.316 0.128 1.37 (1.07, 1.76) 0.01
Female (ref: male)  
 
-0.365 0.708 0.69 (0.17, 2.78) 0.61
Sexual partners that use injection 
drugs (ref: sexual partners do not 
use injection drugs) 
 
1.925 0.779 6.85 (1.49, 31.55) 0.01
Sex trade work history (ref: no 
history of sex trade work) 
 
3.313 4.387 27.46 
(0.01, 148789.80) 
0.45
Emotional abuse history 
(ref: never emotionally abused) 
 
1.795 0.938 6.02 (0.96, 37.80) 0.06
Have attempted suicide 
(ref: never attempted suicide) 
 
0.792 0.480 2.21 (0.86, 5.66) 0.10
History of incarceration 
(ref: no history of incarceration) 
 
1.924 0.741 6.85 (1.60, 29.25) 0.01
Ever lived on the streets 
(ref: never lived on the streets) 
 
-11.052 4.626 0.001 (0.001, 0.14) 0.02
Sex trade work history by gender 
 
 
3.770 1.172 43.39 
(4.36, 431.55) 
0.00
Sex trade work history by age 
 
-0.464 0.209 0.63 (0.42, 0.95) 0.03
Living on the street history by age 0.582 0.242 1.79 (1.12, 2.88) 0.02
-2 log likelihood = 135.137  
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4.3.2.4  The relationship between sex trade history, gender in street youth and 
injection drug use.  
A significant finding in the model was the interaction between sex trade and 
gender in those participants identified as having used injection drugs (see Figure 4-9). 
Firstly, females were more likely than males to be involved in the sex trade. Secondly, 
females are more likely to use injection drugs when they are involved in the sex trade as 
compared to their injection drug use when not involved in the sex trade. Conversely, 
males were more likely to use injection drugs when they were not involved in the sex 
trade as compared to their injection drug use when involved in the sex trade. 
4.3.2.5  The relationship between sex trade history, age of street youth and 
injection drug use. 
Interaction between sex trade and age for injection drug use was also identified as 
being significant in the multivariate model as seen in Figure 4-10. In younger age groups, 
having used injection drugs is less likely to occur if youth had not participated in the sex 
trade. However, in older age groups, use of injection drugs occurred regardless if youth 
participated in the sex trade or not. 
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Figure 4-9. Proportions of street youth participants with using injection drugs by sex 
trade participation and gender 
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Figure 4-10. Proportions of street youth participants with using injection drugs by sex 
trade work participation and age. 
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4.3.2.6 The relationship between living on the street history, age of street youth 
and injection drug use.  
A significant finding in the model was the interaction between history of living on the 
street and age in those participants who have identified as having used injection drugs as 
seen in Figure 4-11. This interaction identifies that the proportion of youths having used 
injection drugs is highest in young adulthood. Injection drug is similar in early age 
groups. Injection drug use increases dramatically in those participants with a previous 
history of living in the streets. 
4.3.3 Research Question 3  
What characteristics are associated with Hepatitis C Virus in Saskatoon street youth? 
 Selected demographic and risk behaviors for HCV status are compared in Table 
4-13. From this table it can be seen that participants infected with HCV were 
significantly older than those youth without infection (t = -2.91, df = 154, p = 0.004), 
were more likely to be female (χ² = 4.76, df = 1, p = 0.03) and be Aboriginal (χ² = 3.79, 
df = 1, p = 0.08 FET). Although participants with HCV were more likely to have body 
piercing and to have one or more tattoos, the latter findings were not significant. 
 Other substance use examined by HCV status included non-injection drugs, 
alcohol use and smoking cigarettes. All HCV participants smoked cigarettes and had used 
common street drugs. Participants that were HCV negative were more likely to drink 
alcohol regularly (43.3%) than those participants that were HCV positive (20.0%). 
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Figure 4-11. Proportions of street youth participants having used injection drugs by 
living on the street and age. 
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Table 4-13 
Demographic and Risk Behaviors Associated with Hepatitis C Virus in Saskatoon Street 
Youth Participants (n = 156) 
 
Variable (%) HCV Positive
n = 15
HCV Negative 
n = 141 
Total HCV
N = 156
Age mean(SD)¹ 
 
19.9 (2.85) 17.8 (2.57) 18.0 (2.65)
Gender² 
     Male 
     Female 
 
5 (33.3) 
10 (66.7)
 
88 (62.4) 
53 (37.6) 
93 (59.6) 
63 (40.4)
Aboriginal ethnicity³* 
     No 
     Yes 
 
0 (0.0) 
15 (100)
 
29 (20.6) 
112 (79.4) 
29 (18.6) 
127 (81.4)
One or more tattoos 
     No 
     Yes 
 
6 (40.0) 
9 (60.0)
 
75 (53.2) 
66 (46.8) 
81 (51.9) 
75 (48.1)
Body piercing³* 
     No 
     Yes 
 
2 (13.3) 
13 (86.7)
 
49 (34.8) 
92 (65.2) 
51 (32.7) 
105 (67.3)
Use of injection drugs 4∗∗ 
     Never 
     Once 
     More than once  
 
4 (68.8) 
1 (6.7) 
10 (66.7)
 
97 (68.8) 
16 (11.3) 
28 (19.9) 
101 (64.7) 
17 (10.9) 
38 (24.4)
Age of first injection (SD) 
 
16.6 (1.66) 15.38 (1.34) 15.5 (1.41)
Use of Ritalin by injection4* 
(past 3 months) 
     No 
     Yes 
 
7 (46.7) 
8 (53.3)
 
 
122 (86.5) 
19 (13.5) 
129 (82.7) 
27 (17.3)
Ever used unclean equipment4 
     No 
     Yes 
 
11 (73.3) 
4 (26.7)
 
136 (96.5) 
5 (3.5) 
147 (94.2) 
9 (5.8)
¹p < 0.01; ²Р< 0.05; ³р < 0.10; 4p< 0.001  
∗ Fishers Exact Test 
∗∗  2 cells (33.3%) have expected count less than 5. The minimum expected count is 1.63. 
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Table 4-13 (continued) 
Demographic and Risk Behaviors Associated with Hepatitis C Virus in Saskatoon Street 
Youth Participants (n = 156) 
 
 
Variable (%) HVC Positive HVC Negative Total HVC
Non-injection drug use 
     No 
     Yes 
 
0 (0.0) 
15 (100.0)
 
6 (4.3) 
135 (95.7) 
6 (3.8) 
150 (96.2)
Regular use of alcohol³ 
     No 
     Yes 
 
12 (80.0) 
3 (20.0)
 
80 (56.7) 
61 (43.3) 
92 (59.0) 
64 (41.0)
Smoke cigarettes 
     No 
     Yes 
  
0 (0.0) 
15 (100)
 
11 (7.8) 
130 (92.2) 
11 (7.1) 
145 (92.9)
Mean lifetime sexual partners (SD) 
 
46.9 (129.85) 18.6 (48.87) 21.3 (61.24)
Sex trade history 
    No 
    Yes 
 
8 (53.3) 
7 (46.7)
 
102 (72.3) 
39 (27.7) 
110 (70.5) 
46 (29.5)
³р < 0.10 
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Injection drug use was common with 73.3% (n = 11/15) of HCV infected youth 
reporting this behavior (χ² = 10.54, df = 1, p< 0.001). Use of Ritalin by injection (χ² = 
15.05, df = 1, p = 0.001 FET), a history of using unclean equipment with injection drug 
use (χ² = 13.33, df = 1, p = 0.005), and age of first injection (t = -3.28, df = 154, p = 
0.001) were all associated with HCV positive status. Table 4-14 examines selected 
characteristics of injection drug users by HCV screening. Frequency of injection on a 
weekly basis, and mean years of using injection drugs were not significant between HCV 
positive and negative groups. However, it is worth noting that there was a trend for 
63.6% of participants to use injection drugs for two years or less had HCV infection and 
36.4% to use injection drugs for six years or more had HCV infection. 
Table 4-15 shows further population characteristics specific to variables of culture 
of homelessness. A history of sex trade work was higher for HCV positive participants 
(χ² = 2.36, df = 1, p = 0.14 FET). Participants infected with HCV were more likely to 
have any history that included emotional abuse (χ² = 7.302, df = 1, p = 0.02), physical 
abuse (χ² = 5.104, df = 1, p = 0.06), and sexual abuse (χ² = 6.023, df = 1, p = 0.02 FET). 
More HCV positive participants reported being depressed at the time of the 
interview and had attempted suicide in their lifetime compared to those who were not 
infected with HCV. HCV positive participants were more likely not to attend school (χ² = 
3.23, df = 1, p = 0.07), not live with their parent/caregiver (χ² = 2.38, df = 1, p = 0.12), 
have lived in a group home (χ² = 3.47, df = 1, p = 0.06), or have lived on the streets at 
some point in their lives (χ² = 3.70, df = 1, p = 0.08 FET). 
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Table 4-14 
Injection Drug Use Characteristics of Participants who Consented to Hepatitis C Virus 
Screening (n = 55) 
 
Variable HCV Positive
n = 11 (20%)
HCV Negative 
n = 44 (80%) 
Total IDU
N = 55 (%)
Gender¹ 
      Male 
      Female 
 
3 (27.3) 
8 (72.7)
 
25 (56.8) 
19 (43.2) 
28 (50.9) 
27 (49.1)
Mean age of first injection(SD)² 
 
17.0 (1.79) 15.1 (2.39) 15.5 (2.39)
By age category¹ 
     <14 years 
     14 to 16 years 
     17-18 years 
     >18 years    
 
0 (0.0) 
4 (36.4) 
5 (45.5) 
2 (18.2)
 
13 (29.5) 
20 (45.5) 
8 (18.2) 
3 (6.8) 
13 (23.6) 
24 (43.6) 
13 (23.6) 
5 (9.1)
Frequency of injection/week (SD) 
 
20.2 (24.19) 27.0 (73.79) 25.6 (66.72)
 
    Ritalin by injection²* 
 
    Morphine by injection 
 
    Cocaine by injection 
 
8 (72.7) 
 5 (45.4) 
4 (36.4)
 
19 (43.2) 
 
15 (34.1) 
  
12 (27.3) 
27 (49.1) 
20 (36.4) 
16 (29.1)
Mean years of injecting(SD) 
 
3.6 (2.77) 3.9 (2.68) 3.9 (2.68)
By year category ¹ 
      ≤ 2 years 
     3 years 
     4-5 years 
     ≥ 6 years 
 
7 (63.6) 
0 (0.0) 
0 (0.0) 
4 (36.4)
 
15 (34.1) 
8 (18.2) 
10 (22.7) 
11 (25.0) 
22 (40.0) 
8 (14.5) 
10 (18.2) 
15 (27.3)
Used unclean equipment¹* 4 (36.4) 5 (11.4) 9 (16.4)
¹p < 0.10; ²p < 0.05  
* by Fishers Exact Test 
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Table 4-15 
Culture of Homelessness Variables Associated with Hepatitis C Virus in Saskatoon Street 
Youth Participants (n = 156) 
 
Variable (%) HVC Positive HVC Negative Total HVC
Sexual abuse history¹ 
    No 
    Yes 
 
8 (53.3) 
7 (46.7)
 
114 (80.9) 
27 (19.1) 
122 (78.2) 
34 (21.8)
Emotional abuse history² 
     No 
     Yes 
 
11 (73.3) 
4 (26.7)
 
132 (95.0) 
9 (5.0) 
143 (91.7) 
13 (8.3)
Physical abuse history¹ 
     No  
     Yes 
 
12 (80.0) 
3 (20.0)
 
134 (95.0) 
7 (5.0) 
146 (93.6) 
10 (6.4)
Depressed¹ 
     No 
     Yes 
 
7 (46.7) 
8 (53.3)
 
105 (94.5) 
36 (25.5) 
112 (71.8) 
44 (28.2)
Attempted suicide¹ 
    No 
    Yes 
 
5 (33.3) 
10 (66.7)
 
92 (65.2) 
49 (34.8) 
97 (62.2) 
59 (37.8)
Attending school³ 
     No 
     Yes 
11 (73.3) 
4 (26.7)
 
69 (48.9) 
72 (51.1) 
80 (51.3) 
76 (48.7)
Live with parent/caregiver (daily) 
     No 
     Yes 
 
11 (73.3) 
4 (26.7)
 
74 (52.5) 
67 (47.5) 
85 (54.5) 
71 (45.5)
Ever in detention or jail 
     No 
     Yes 
 
3 (20.0) 
12 (80.0)
 
44 (31.2) 
97 (68.8) 
47 (30.1) 
109 (69.9)
Main income of social welfare 
     No 
     Yes 
 
9 (60.0) 
6 (40.0)
 
98 (69.5) 
43 (30.5) 
107 (68.6) 
49 (31.4)
 
¹p < 0.05; ²Р < 0.01; ³р < 0.10  
* by Fishers Exact Test 
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Table 4-15 (continued) 
Culture of Homelessness Variables Associated with Hepatitis C Virus in Saskatoon Street 
Youth Participants (n = 156) 
Variable (%) HVC Positive HVC Negative Total HVC
Ever had social worker 
     No 
     Yes 
 
5 (33.3) 
10 (66.7)
 
46 (32.6) 
95 (67.4) 
51 (32.7) 
105 (67.3)
Ever been in foster care 
     No 
     Yes 
 
4 (26.7) 
11 (73.3)
 
59 (41.8) 
82 (58.2) 
63 (40.4) 
93 (59.6)
Ever been in a group home³* 
     No 
     Yes 
 
6 (40.0) 
9 (60.0)
 
91 (64.5) 
50 (35.5) 
97 (62.2) 
59 (37.8)
Ever lived on streets³* 
     No 
     Yes 
7 (46.7) 
8 (53.3)
 
100 (70.9) 
41 (29.1) 
107 (68.6) 
49 (31.4)
 
¹p < 0.05; ²p < 0.01; ³р < 0.10  
* by Fishers Exact Test 
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4.3.3.1 Summary of findings for population characteristics with Hepatitis C Virus. 
This analysis compared HCV between street youth participants who were HCV 
antibody positive with those youth who were HCV antibody negative as the reference. A 
number of characteristics were found to be significant for HCV status at the univariate 
level. Results of univariate analysis including odds ratios (OR) and confidence intervals 
(CI) to assess variables associated with injection drug use are seen in Table 4-16. These 
finding reflect observations made in the descriptive analysis. Strong associations with 
HCV, as observed at (p ≤ 0.01) were found for age, injection drug use, use of Ritalin by 
injection, use of unclean equipment, age of first injection, and history of emotional abuse. 
Variables associated with HCV with a univariate significance level of p ≤ 0.25 were 
considered for entry into the multivariate model.   
 
 
75 
Table 4-16 
Univariate OR (95% CI) Results for Variables Associated with Hepatitis C Virus 
 
 
Variable  OR 95% CI 
Gender 
 
3.32 1.08 - 10.24 
Aboriginal ethnicity 
 
1.13 1.06 - 1.21 
Body piercing 
 
3.46 0.75 - 15.96 
Ever used injection drugs 
 
6.06 1.83 - 20.10 
Use of Ritalin by injection (past 3 months) 
 
7.34 2.39 - 22.57 
Ever used unclean equipment 
 
9.89 2.32 - 42.22 
Regular use of alcohol 
 
0.33 0.09 - 1.21 
Sex trade history 
 
2.29 0.78 - 6.74 
Abuse history (physical/emotional/sexual) 
 
3.60 1.22 - 10.65 
Depressed 
 
3.33 1.13 - 9.84 
Attempted suicide 
 
3.76 1.22 - 11.60 
Not attending school 
 
0.35 0.11 - 1.15 
Not living with parent/caregiver (daily) 
 
0.40 0.12 - 1.32 
Ever been in a group home 
 
2.73 0.92 - 8.11 
Ever lived on streets 
 
2.79 0.95 - 8.19 
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 4.3.3.2 Multivariate analysis. 
 
Based on a p-values of ≤ 0.25 or clinical relevance, variables chosen for the full 
model included: age, gender, body piercing, use of Ritalin by injection, use of unclean 
equipment for injection, age of first injection, regular use of alcohol, history of sex trade 
work, abuse history (sexual, physical, and/or emotional), depression, attempted suicide, 
not attending school, not living with parents/caregiver on a daily basis, having lived in a 
group home, and having lived on the streets. Variables to be included in the model were 
then tested for interaction by age and gender using logistic regression. The interaction 
between age of first injection by gender for HCV was found to be significant (p = 0.02) 
and therefore was included in the full model. Aboriginal ethnicity was excluded from the 
model because every HCV antibody positive case was Aboriginal. Results of the model 
analysis are presented in Table 4-17. 
The significance for retention in the model was set at p < 0.05. The full model 
was reduced by removing significantly unimportant variables one at a time. The variables 
of depression, not attending school, having lived in a group home, and regular alcohol 
use was removed from the full model one at a time. Model building analysis can be seen 
in Appendix H.  
The final model, presented in Table 4-18 included variables of: age, gender, body 
piercing, use of Ritalin by injection, use of unclean equipment for injection, age of first 
injection, age of first injection by gender, suicide, history of sex trade work, history of 
abuse, not living with parents/caregivers, and history of living on the street. Significant 
positive associations continued for use of Ritalin by injection, history of living on the 
street, and age of first injection in the final model. 
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Table 4-17 
Full Model using Logistic Regression comparing the HCV Positive Group to the HCV 
Negative Group 
χ² = 44.838, df = 16, р < 0.001 
Variable ß SE OR (95%CI) p-value
Age 
 
-0.009 0.211 0.99 (0.66, 1.50) 0.97
Female (ref: male)  
 
-19.786 11.206 0.00 (0.00, 8.99) 0.08
Body piercing (ref: no piercing) 
 
 0.895 1.173 2.45 (0.25, 24.38) 0.45
Use of Ritalin by injection (ref: 
never used Ritalin by injection) 
 
1.806 1.026 6.08 (0.81, 45.44) 0.08
Use of unclean equipment  
(re: use of clean equipment) 
 
0.826 1.264 2.29 (0.19, 27.20) 0.51
Age of first injection 
 
-1.284 0.905 0.28 (0.05, 1.63) 0.16
Regular use of alcohol 
(ref: non-regular use) 
 
-1.517 0.977 0.22 (0.03, 1.49) 0.12
Sex trade history 
(ref: never involved in sex trade) 
 
-2.567 1.590 0.08 (0.00, 1.73) 0.11
Abuse history (ref: never sexually, 
emotionally, or physically abused) 
 
0.511 0.892 1.67 (0.29, 9.58) 0.57
Depressed 
(ref: not depressed) 
 
0.088 0.897 1.09 (0.19, 6.34) 0.92
Attempted suicide 
(ref: never attempted suicide) 
 
1.489 0.947 4.43 (0.69, 28.38) 0.12
Not attending school 
(ref: attending school) 
 
-0.634 0.993 0.53 (0.08, 3.71) 0.52
Not living with parent/caregiver 
(daily)(ref: daily living with 
parents/caregiver) 
 
0.622 0.949 1.86 (0.29, 11.96) 0.51
-2 log likelihood = 54.829 
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Table 4-17 (continued) 
Full Model using Logistic Regression comparing the HCV Positive Group to the HCV 
Negative Group 
 
χ² = 44.838, df = 16, р < 0.001 
Variable ß SE OR (95%CI) p-value
Ever lived in a group home 
 
0.504 0.827 1.66 (0.33, 8.38) 0.54
Ever lived on streets 
(ref: never lived on the streets) 
 
 
2.002 0.988 7.40 (1.07, 51.31) 0.04
Age of first injection by gender 1.354 0.721 3.87 (0.94, 15.93) 0.06 
(ref: never lived in a group home) 
-2 log likelihood = 54.829 
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Table 4-18 
Final Model using Logistic Regression comparing the HCV Positive Group to the HCV 
Negative Group 
Variable ß SE OR (95%CI) p-value
Age 
 
0.056 0.188 1.06 (0.73, 1.53) 0.77
Female (ref: male)  
 
-19.636 10.784 0.00 (0.00, 4.49) 0.07
Body piercing (ref: no piercing) 
 
0.623 1.017 1.86 (0.25, 13.68) 0.54
Use of Ritalin by injection (ref: 
never used Ritalin by injection) 
 
1.845 0.900 6.33 (1.08, 36.94) 0.04
Use of unclean equipment  
(re: use of clean equipment) 
 
0.590 1.161 1.80 (0.19, 17.56) 0.61
Age of first injection 
(ref: never used injection drugs) 
 
-1.305 0.866 0.27 (0.05, 1.48) 0.13
Sex trade history 
(ref: never involved in sex trade) 
 
-2.507 1.412 0.08 (0.01, 1.30) 0.08
Abuse history (ref: never sexually, 
emotionally, or physically abused) 
 
0.869 0.800 2.38 (0.50, 11.44) 0.28
Attempted suicide 
(ref: never attempted suicide) 
 
1.586 0.879 4.89 (0.87, 27.36) 0.07
Not living with parent/caregiver 
(daily)(ref: daily living with 
parents/caregiver) 
 
0.739 0.890 2.09 (0.37, 11.98) 0.41
Ever lived on streets 
(ref: never lived on the streets) 
 
1.873 0.941 6.51 (1.03, 41.19) 0.05
Age of first injection by gender 1.350 0.693 3.86 (0.99, 15.01) 0.05
 
χ² = 39.972, df = 12, р < 0.001 
-2 log likelihood = 58.792 
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4.3.3.3 Model diagnostics. 
The fit of the final model was evaluated using the likelihood ratio test (Hosmer & 
Lemeshow, 2000). The reduced model did not differ from the final model (χ² = 3.963, df 
= 4, p > 0.05), thus the final model appeared to have good fit. 
4.3.3.4 The relationship between age of first injection by gender 
A significant finding in the model was the interaction term for HCV, that being, 
age of first injection by gender as seen in Figure 4-12. In this study, HCV infection is 
higher in females who initiated injection drug use at a later age. More males than females 
with HCV initiated injection drug use prior to age 15 years. Previous results identified 
more females were engaging in injection drug use at an earlier age than males (see Table 
4-6), however, these females are not being identified as having HCV. 
4.4 Summary of Results 
 The results of this analysis provide some important information regarding 
injection drug use and HCV in the Saskatoon street youth community. With regards to 
prevalence of injection drug use and associated characteristics, the following findings are 
of interest: 
1. The prevalence of injection drug use in Saskatoon street youth was 32.8%. 
2. Females were more likely to initiate injection drug use, repeat this behavior at a 
younger age, and use injection drugs for a longer period of time as compared to 
males. 
3. Females were more likely to use unclean drug paraphernalia than males. 
4.  The drug of choice by injection was Ritalin. Frequency of injection drug use for 
females was greater than that in males. 
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Figure 4-12. Proportions of street youth participants with Hepatitis C Virus by age of 
first injection and gender.  
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5. Risks found to be significantly associated with injection drug use include: age, 
having sexual partners that use injection drugs, history of incarceration, and 
having lived on the streets.  
6. Significant interaction was seen for injection drug use including sex trade work 
and gender, sex trade work and age, and ever lived on the street and age.   
With regard to HCV and associated characteristics, the following findings are of interest: 
1. The prevalence of HCV was 9.6%.  
2. Participants infected with HCV tend to be older, female and Aboriginal. 
3. Injection drug use was the strongest risk factor for HCV in street youth 
population.  
4. Risks found to be associated with HCV included Ritalin by injection and history 
of living on the street.  
5. There was a direct increase in the prevalence of HCV with age of first injection 
for female youth. 
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Chapter 5: Discussion 
 The purpose of the analysis was to firstly, determine the prevalence of injection 
drug use and Hepatitis C Virus in street involved youth in Saskatoon, Saskatchewan. 
Secondly, this study was undertaken to describe the behaviors and determinants of street-
related behaviors in relation to injection drug use and Hepatitis C Virus. The results will 
be discussed in relation to the three research questions that directed the analysis  
5.1 Research Question 1 
What is the prevalence of injection drug use and Hepatitis C Virus in Saskatoon street 
youth? 
 The research findings in the Saskatoon study regarding the role of injection drug 
use in the transmission of HCV are consistent with those obtained nationally. The 
prevalence rate of injection drug use in Saskatoon was higher (32.8%) than the overall 
prevalence determined in the same phase of the Enhanced Surveillance of Canadian 
Street Youth Study (17.9%).  This prevalence rate is comparable to other recent studies of 
injection drug use prevalence among street youth populations. In Montreal, the 
prevalence of injection drug use was 46% (Roy et al, 2001) and the prevalence in Ottawa 
was 17% (Slinger et al, 2001). 
 The prevalence of HCV in the Saskatoon street youth population was twelve 
times higher (9.6%) than the estimated HCV prevalence of 0.8% in the general Canadian 
Population (Remis, 1998). In addition, the HCV prevalence in this study was twice as 
high as the HCV prevalence of 4.1% determined in the overall Enhanced Surveillance of 
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Canadian Street Youth Phase III Study (Health Canada, 2003). This HCV rate is within 
the range of findings from other street youth populations with 12.6% in Montreal (Roy et 
al, 2001) and 4% in Ottawa (Slinger et al, 1999).  
The 20% prevalence of HCV infection in this study’s injection drug users was 
much higher than the 9.6% seen in the overall Saskatoon sample. Previous studies that 
have 100% injection drug use samples with similar age groupings, as that of the 
Saskatoon sample, demonstrate HCV prevalence to range from 19.2% in Regina (Regina 
Health District, n.d.) to 46% in Vancouver (Miller et al, 2002). The HCV prevalence rate 
of 20%, in the IDU Saskatoon sample, falls within the lower end of this range. Thus, 
populations with a higher prevalence of injection drug use behavior have a 
correspondingly higher rate of HCV. Diversity in prevalence rates across the country 
demonstrates the need for data to be specific to where the risk behavior occurs so those 
characteristics of this risk behavior can be understood and interventions can be adapted to 
that behavior. 
5.2 Research Question 2 
What characteristics are associated with injection drug use in Saskatoon street youth? 
Several important associations between population characteristics and injection 
drug use have been identified in this study. Factors found to be associated for using 
injection drugs in the Saskatoon street population include: older age, having sexual 
partners that also use injection drugs (in the three months prior), a history of 
incarceration, and having lived on the street. As well, three interactions were found to be 
significantly associated with injection drug use which include sex trade by age and by 
gender, and living on the street by age.  
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Age was found to be significantly associated with injection drug use. The overall 
mean age of 17.9 years within these youth was younger when compared to other studies 
examining street populations. In the study by Roy et al (2001), Montreal street youth had 
a mean age of 19.5 years, while in Vancouver the median age was 21 years (Miller et al., 
2002).  
Street youth having sexual partners that use injection drugs was strongly 
associated with their own injection drug use. Evans et al. (2003) found that females were 
more likely than males to have injection drug using sex partners, however this gender 
difference was not seen in this analysis. Injection drug use in the context of sexual 
relationships may represent a social behavior among young users (Weibe & Reimer, 
2000) and indicates interventions need to target risk behavior at the partnership level 
(Evans et al, 2003). 
After adjusting for age and gender, history of incarceration was strongly 
associated with injection drug use (p < 0.01). This finding is important, especially 
considering the overall sample excluded those youth who had been recruited to the total 
study from a correctional facility.  Prison populations have a significant portion of people 
who either currently use injection drugs or have a history of doing so. Drugs are quite 
available in prison settings and many offenders report using injecting drugs began while 
in prison (Provincial Strategy Team on Blood Borne Pathogens and Injection Drug Use, 
2000).  Those study subjects who had previously been in correctional settings may be at 
higher risk for HCV infection because of lack of access to sterile drug paraphernalia and 
other harm reduction measures while in these environments (Weibe & Reimer, 2000).  
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 In the final model, a history of living on the street was found to be independently 
associated with injection drug use behavior in this street youth population. Other 
determinants that place people at higher risk for injecting drugs include poverty, 
homelessness, lack of education, family dysfunction, parental substance abuse, mental 
health problems, and child abuse (ACPH, 2001). At the univariate level, all of these 
determinants with the exception being parental injection drug use were associated with 
injection drug use. After controlling for other factors, living in the street was a significant 
risk factor for injection drug use. Homelessness and shelter associated with injection drug 
use has been identified previously in the literature (Strathdee, 1997; Miller et al, 2002). 
Lack of affordable housing has been linked to injection drug use in Vancouver in which 
needle sharing and concentrations of young injection drug users within one small area 
(Vancouver’s downtown East side) have contributed to the spread of blood-borne 
infections (Strathdee, 1997; Miller et al, 2002). Although Saskatoon does not have the 
same visible homelessness or volumes of homeless individuals as Vancouver’s 
downtown east side, Saskatoon does have a concentration of injection drug use and sex 
trade activity in its inner city.  Clearly housing and safe shelter is a concern for these 
youth, however it is unknown where these study participants resided. 
The interaction of living on the street by age was strongly associated with using 
injection drugs. This interaction is seen in youth over 20 years of age in those with a 
history of living in the street continuing to use injection drugs. Youth often become 
homeless because of a failure in family, school, community, child protection services, 
and youth correction systems that normally keep youth anchored in mainstream society. 
Once on the street, youth by circumstance and necessity participate in high-risk 
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behaviors, including injecting drugs (Caputo, Weiler & Anderson, 1997; Higgitt, 2003). 
In Saskatoon’s Community Plan for Homelessness and Housing (City of Saskatoon, 
2003), youth are identified as being over-represented among the population of homeless 
and are also over-represented among the population at-risk of becoming homeless. This 
study has identified the many associations between social support and justice systems and 
injection drug use. One has to question if these support systems failed these youth in 
providing adequate supports. In the current study, there was a strong association for 
homeless youth to engage in injection drugs and this risk behavior continues to escalate 
while youth remain on the street. Support systems have to change in order to address the 
needs of street youth appropriately. Prevention strategies are needed early on before these 
youth engage in this risk behavior.  
The interactions of sex trade by age and by gender were significantly associated 
with injection drug use. Literature on sex trade activities identifying such interactions 
could not be located, indicating either a gap in the literature or unpublished findings. 
Analysis identified that females, who use injection drugs, were more likely than males to 
be involved in the sex trade. Conversely, males were less likely to use injection drugs 
when involved in the sex trade. Three hypotheses are generated from this interaction: 
First, it is hypothesized that the increase in female sex trade workers to use injection 
drugs implies drug dependency as a coping mechanism to endure trading sex. A national 
consultation project examining Canadian Aboriginal children and youth speaking out 
about sexual exploitation found Aboriginal youth used drugs to provide a mental and 
emotional break thereby sedating the feelings surrounding sex trade work (Kingsley, 
1995). In addition, youth reported heavy drug use after entering the sex trade (Kingsley, 
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1995). A second hypothesis generated by the interaction seen is that sex is traded as a 
means to support the drug dependency. This hypothesis is also supported in Kingsley’s 
findings where youth reported being forced into the trade through the need to support 
their addiction (1995). Lastly, an increase in sex trade by females and using injection 
drugs could result from pimps using drug dependency to ensure compliancy on the part of 
the sex trade worker. It is unclear how the interaction identified impacts males. 
When examining the interaction between sex trade by age and injection drug use, 
such use is seen in higher age groups where prevalence of injection drug use continues, 
despite decreased sex trade involvement. Currently, there is no literature that supports or 
conflicts with this finding. Sex trade in the street youth population has been previously 
identified in the literature (Kidd & Kral, 2002; Weber, Boivin, Blais, Haley, & Roy, 
2002). Weber et al. (2002) found females aged 14 to 25 having a history of injection drug 
use were four times more likely to report having been involved in the sex trade thereby 
being at increased risk for HIV infection. In a qualitative analysis Kidd & Kral (2002) 
found that trading sex was linked with suicidal experiences. It is further noted that drug 
abuse was perceived by participants as a slow suicide. 
Emotional abuse had borderline significance (p = 0.06) in the final model. It is 
believed that abuse in the home, including that of emotional abuse, is a major pathway to 
the street lifestyle (Radford, King, & Warren, 1989; Caputo, Weiler & Anderson, 1997).  
Other studies have indicated that a history of emotional abuse is related to engaging in 
drug abuse and other high-risk behaviors (Hibbard, Ingersoll & Orr, 1990; Walker, 
Gelfand, Katon, Koss, Von Korff & Russo, 1999; Moeller, Bachmann & Moeller, 1993).  
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Although Aboriginal ethnicity was not found to be associated with injection drug 
use, it is worth noting that 86.9% (n = 53/61) of participants report being Aboriginal and 
having used injection drugs. Although literature specific to Aboriginal people and 
injection drug use are limited, one study (Mill, 1997), identified injection drug use as a 
survival technique for Aboriginal women that have low self-esteem. Using drugs and 
alcohol has also been identified in the literature examining street youth, as a coping 
strategy to deal with stress and depression (Ayerst, 1999). 
5.3 Research Question 3 
What characteristics are associated with Hepatitis C Virus in Saskatoon street youth? 
 Several important associations between potential risk factors and HCV that were 
identified during the multivariate analysis, included use of Ritalin by injection, having 
ever lived in the street, and interaction between age of first injection and gender for HCV. 
 Other studies have identified injection drug use as a major route of transmission 
for HCV in street youth (Diaz et al, 2001; Hahn et al, 2001; Regina Health District, n.d.; 
Miller et al, 2002; Patrick et al, 2001; Roy et al, 2001; Thorpe et al, 2000). Overall, 
injection drug use was associated with HCV in the study population. Ritalin was the drug 
most often chosen for injection by participants. The variable for Ritalin was chosen for 
analysis versus the injection drug use variable, because the injection drug use variable 
was unstable having two cells with expected count less than five (see Table 4-13) and had 
a negligible level of significance by comparison (Ritalin: p = 0.001; injection drug use: p 
< 0.001). Within this study, after adjusting for age, gender, and other risk factors for 
HCV, use of Ritalin by injection showed the strongest association with HCV with a six-
fold increase in the probability of having an antibody HCV positive result. This finding is 
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unique from other studies. Most studies have reported cocaine use by injection (Miller et 
al, 2002; Roy et al, 2001; Patrick et al, 2001), and heroin or speedballs by injection 
(Miller et al, 2002) as being predictors of HCV. Cocaine has been identified as the drug 
of choice among many Canadians who use injection drugs (Wiebe & Reimer, 2000), 
however the ages of the users in these studies were older and not typical of street youth 
populations.  Ritalin is the drug most commonly prescribed in the treatment of attention 
deficit disorder with hyperactivity in children (Provincial Strategy Team on Blood Borne 
Pathogens and Injection Drug Use, 2000). Ritalin is widely available and thus, may have 
been more accessible to this age group. Ritalin has been identified as the drug most 
commonly injected in studies from other parts of Saskatchewan. In the Prince Albert 
sero-prevalence study Ritalin was used by 70% of those studied (Provincial Strategy 
Team on Blood Borne Pathogens and Injection Drug Use, 2000). In the Regina study, 
16.5% of subjects used Ritalin by injection (Regina Health District, n.d.). 
A history of living on street was identified in the final model as being strongly 
associated with HCV infection. This finding is unique. In previous studies examining 
predictors of HCV, the exact living circumstances of street youth were not examined. 
These studies tended to focus on associations with transmission of HCV versus social and 
environmental characteristics. High-risk behaviors which include multiple sexual partners 
(Beech, Myers & Beech, 2002; Miller et al, 2002); sharing/borrowed drug paraphernalia 
(Diaz et al, 2001; Hahn et al, 2001; Regina Health District, n.d.; Thorpe et al, 2000), 
working in the sex trade (Miller et al, 2002) and tattooing (Roy et al, 2001) have been 
identified as predictors of HCV. Each of these risk behaviors was entered in the full 
model analysis, however none of these variables were found to be significantly associated 
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with HCV.  It is disturbing that many of the participants reported living on the street. The 
exact reasons for this behavior were not examined in this study and further study of the 
street environment lifestyles of youth would be useful. 
  Findings from this study showed that compared with males, females infected with 
HCV are initiating more injection drug use after the age of 15. Prevalence of HCV is seen 
to increase with older age of initiation into injection behavior. Older age of injection has 
been identified as being predictive of HCV in other studies (Beech, Myers & Beech, 
2002; Hahn et al, 2001; Miller et al, 2002; Roy et al, 2001). The trend towards more 
females using injection drugs and having HCV infection is consistent with other studies 
(Patrick et al, 2001). 
This study did not associate length of time injecting with HCV infection. 
However, we cannot ignore that 63.6% of youth acquired HCV within the first two years 
of injecting. Diaz et al (2001) found using injection drugs for three years or more was 
associated with HCV. A study of injection drug use in young adults in San Francisco 
found 9% HCV prevalence in those who had been injecting for less than two years, rising 
to 78% in those who had injected for ten years or more (Hahn et al, 2001). The Regina 
study (n.d.) of youth and adults found the likelihood of becoming infected with HCV 
increased by 10% per year for every year that a person injected drugs. The Chicago 
study, again an adult population, found those who had injected for one to four years were 
nearly three times more likely to have HCV; those who had injected for more than four 
years were ten times more likely to have HCV infection (Thorpe et al, 2000). This 
apparent lack of association between length of use and HCV infection in the current study 
is unusual but may be a function of the study’s population characteristics as the sample 
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included a sub-group of young injection drug users, many with short durations of 
injection behavior. This study contrasts with the other studies above, in that their samples 
are comprised entirely with injection drug users whereas the current study included all 
street youth whether injecting or not.  
Other studies have found the sharing or borrowing of syringes or other drug 
paraphernalia as predictors of HCV (Diaz et al, 2001; Hahn et al, 2001; Regina Health 
District, n.d.; Thorpe et al, 2000). These studies are based on samples comprised entirely 
of injection drug users. This study did not detect an association between HCV and using 
unclean equipment in multivariate analysis. Only 16.4% of injection drug users reported 
using unclean equipment in this study. It is reasonable to assume that the question was 
either misunderstood or misinterpreted by youth, or information was inaccurately 
reported, or there was limited power to find an association. This finding may also be a 
reflection of the study’s population characteristics or this risk behavior may not correlate 
with HCV infection, particularly when this risk behavior is low.  
 All HCV positive participants in this sample were Aboriginal. Therefore, it is 
reasonable to assume that Aboriginal street youth may be at particular risk for HCV in 
Saskatoon. A study conducted in Vancouver found Aboriginal ethnicity to be predictive 
for HCV (Patrick et al, 2001). This may be an important sub-population to examine more 
closely.  
The high prevalence of HCV and the strong association with injection drug use 
suggests there is a very small window of opportunity in prevention of HCV once 
injection drug behavior is initiated. The need for interventions targeted early in injection 
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drug use or those contemplating the behavior, is essential. This is especially needed for 
the young Aboriginal females in Saskatoon. 
5.4 Methodological Strengths and Limitations of the Study 
 A number of limitations and biases may have been introduced in the primary 
study, which could influence the findings from this secondary analysis. These potential 
limitations will be addressed in this section.  
5.4.1 Selection Bias 
A form of selection bias, self-selection bias, occurs when an individual’s interest 
and motivation for study participation is related to the study, thus influencing the results 
(Torrence, 1997). A self- selection bias may have been introduced in the primary study as 
participants received an honorarium for their study participation. Thus, the possibility 
exists that those youth that were only seeking compensation and not truly representative 
of the target population were included. However, self-selected participants still had to 
meet eligibility criteria of the study in order to be considered as subjects. 
5.4.2 Sampling Bias 
In cross-sectional surveys, such as this study, exposure and disease are assessed at 
the same time. This study design while appropriate for determining prevalence of disease 
does not permit causal inference about association between HCV and exposure (Burns & 
Grove, 1997). However, given that the objective of the analysis was to determine 
prevalence of injection drug use and HCV and to generate various hypotheses regarding 
what risk factors are important for Saskatoon youth, this study design was appropriate to 
complete these objectives.   
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Street youth are often invisible and transient in nature therefore, a random sample 
in the primary study was not possible. Representative surveys often do not capture street 
youth, as sampling schemes of such surveys cannot access participants outside of the 
school system or those without a fixed address. Snowball sampling was the method used 
to recruit youth and has been demonstrated as the best way to survey “hard-to-reach” 
populations (Roy et al, 2001).  Measures were taken in the initial study by Health Canada 
to minimize sampling bias. First, at least three drop-in centers were approached as 
recruitment sites, as youth who are on the streets do not necessarily visit the same drop-in 
centers (2001b). Second, specific requests were made by the research team for agency 
staff to identify participants who were representative of their client population.  Lastly, 
the research team was familiar with the study participants and street youth characteristics, 
having worked directly with these young people. The above measures taken during the 
sampling process were intended to minimize biases to ensure the sample was as 
representative of the street youth population as possible.  
5.4.3 Response Bias  
The data in this analysis was largely based on self-reported information by the 
participants as is the case with other studies of injection drug use behavior (Miller et al, 
2002; Hahn et al, 2001; Thorpe et al, 2000). Self-reported data should be interpreted 
cautiously as it is the tendency of participants to provide responses that either present 
themselves favorably, or that are congruent with social norms resulting in inaccurate 
information (Polit & Hyngler, 1995). Strategies that included ensuring confidentiality, 
creating a trusting atmosphere, and encouraging honesty (Polit & Hungler) were used in 
the primary study to reduce response bias. Confidentiality was discussed with participants 
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and was ensured by the process used in data collection and giving test results. 
Participants were assigned a unique identification number that was used on all data forms 
known only to the research team. Following the interview, participants were counseled on 
their risk behaviors as identified during the questionnaire, and referrals were made as 
required.  
5.4.4 Information Bias  
Accuracy of the data was a concern in this analysis as participants might have had 
difficulty recalling and providing reliable information. As was the case with other studies, 
to minimize recall bias, participants were asked questions in reference to the previous 
three months and the questions were asked in relation to significant life circumstances in 
order to help participants remember specific behaviors (Thorpe et al., 2000; Diaz et al., 
2001). Interviewers read aloud the questions and completed the questionnaire for 
participants.  Responses that were not recorded by interviewers, resulted in missing data, 
and may have created a misclassification bias. Questions used on the questionnaire were 
previously assessed for reliability prior to their use in Phase III. 
5.5 Implications for Nursing Practice 
Population characteristics that may contribute to the risk of street youth using 
injection drugs and becoming infected with HCV were examined to provide insight and 
assistance to health professionals delivering prevention interventions and community 
health care. The high HCV prevalence rate among Saskatoon street youth requires 
interventions specific to the risk profiles of these youth. The common link for injection 
drug use and HCV in Saskatoon is the street. Therefore living on the street can serve as a 
valuable marker for injection drug use and developing HCV infection in Saskatoon street 
96 
youth. Because this street relationship is so significant, a greater understanding of 
homelessness, which tends to be more common amongst Aboriginal people, (Health 
Canada, 1999) is needed by health professionals. Many Aboriginal youth migrate to 
urban areas to escape abusive environments on reserves and remote communities 
(Kingsley, 1995). A larger centre is seen as a solution for employment, education, and 
better housing (Health Canada, 1999; Kingsley, 1995). However, once Aboriginal youth 
arrive to the city, they find networks and services are scarce and many of their family and 
friends are in the same situation the youth are in (Kingsley, 1995). Having no where to 
go, youth find themselves in a situation of survival for basic necessities of life (Kingsley, 
1995). Youth are forced to fend for themselves, placing themselves at risk for many 
harms. 
The incidence of HCV among injection drug users and youth, particularly 
Aboriginal youth, suggest that health care professionals need to acquire a better 
understanding of the socio-cultural and behavioral context within which health care is 
provided. Nurses need to understand where this risk behavior comes from or those social 
determinants that predispose youth to drug use as well as the dynamics associated with 
injection drug use. Messages of health promotion and disease prevention need to engage 
street youth while being culturally, socially and developmentally appropriate. Because 
housing and safe shelter is a problem for this youth population, professionals are 
encouraged to seek out street youth social networks and provide health care in non-
traditional settings. Nurses working in prison and detention settings need to offer 
prevention services and harm reduction interventions to young offenders and recognize 
their vulnerability to the outcomes found in the present study.  
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 Once street youth are engaging in injection drugs, the window for opportunity for 
HCV prevention is limited. Intercollaborative interventions to identify and target youth 
early in their risk behavior, or in those contemplating the behavior, are essential. 
Saskatoon’s young Aboriginal females, including those in the sex trade, are at particular 
risk for using injection drugs and HCV infection. Ideally, prevention efforts should be 
aimed at children and youth early in their psychosocial development, long before they 
begin to contemplate use of injection drugs. Nurses are in a pivotal position to work with 
individual youth and the community in providing support and guidance when developing 
and implementing these efforts. 
 Lastly, the prevalence of HCV emphasizes the potential burden of illness that may 
be experienced by healthcare in the years to come. Statistics demonstrate that between 
75% and 85% of all individuals infected with HCV will progress to chronic infection and 
remain as a source of transmission for HCV (LCDC, 1999). Clinical care services will 
need to be available to meet the needs of those infected with HCV (Regina Health 
District, n.d.).  
5.6 Recommendations for Research 
Presently there is no reliable information concerning the adolescent population in 
Saskatoon who use injection drugs or on the size of the street youth population. Research 
to assess the size of these populations would be useful and could provide more accurate 
estimates of prevalence.  
This study identified use of Ritalin as being predictive of HCV infection. The 
finding is in contrast to other Canadian studies where cocaine is reported as the drug most 
often injected. Further understanding why Ritalin is so appealing to the youth populations 
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in Saskatoon and how Ritalin is being diverted to these youth in the first place is needed. 
Surveillance programs could be useful to monitor activity of this drug over time. 
Secondly, further research needs to be conducted on the characteristics of equipment that 
these youth use during the practice of injection, such as equipment used to dissolve and 
divide drugs, as this was not well defined in this study. 
The majority of street youth that used injection drugs in this study were 
Aboriginal. In addition, every HCV positive case was of Aboriginal ethnicity. This may 
be an important sub-population to examine more closely and must be taken into account 
when planning services. Aboriginal groups need to be included in planning and service 
delivery, to ensure culturally appropriate services. The transient nature of street youth 
within Saskatchewan is also worth examining. It would be useful to know if rural and 
remote youth are coming to Saskatoon and if so, are they more likely to live in the street 
environment. 
In this study, prevalence of injection drug use is associated with age. Youth who 
never experienced living in the street appear to be less likely to use injection drugs after 
age 21. A cohort study, following the same youth by age and living on the street, 
compared with youth that have never lived on the street would be useful to determine 
why these youth decrease their injection drug use after adolescence. 
This study has identified strong associations with youth living on the street to 
injection drug use behavior and consequently HCV infection. Youth in this study have 
had many interactions with multiple social support systems, yet despite this, many youth 
may end up on Saskatoon streets. Further understanding is needed in how these support 
systems have failed these youth and allowed them to fall through the social safety net. 
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Research is needed to develop service delivery strategies in the context of health care for 
those youth already on the streets, particularly those female youth involved in the sex 
trade. This understanding is necessary so that interventions can be developed to ideally 
prevent youth homelessness, to provide support to those already on the street, and assist 
those youth who are street entrenched to get out of the street environment and ensure they 
do not return. It is anticipated that additional research by the Saskatoon site in Phase V 
(in 2005) of the overall Enhanced STD Surveillance in Canadian Street Youth Study will 
provide a framework for these interventions. 
5.7 Conclusions 
In this study, the use of injection drugs and HCV infection is clearly prevalent in 
this predominantly Aboriginal street youth sample. The relationship identified between 
HCV and injection drug use was a history of living on the street. This link could serve as 
a valuable marker for use of injection drugs and developing HCV infection in street 
youth.  Knowledge of risk factors and causes for injection drug use and HCV provides 
important contextual information about the health states of street youth that health 
professionals need to recognize. New and innovative prevention and harm reduction 
interventions adapted to the profiles of these youth are needed for those that are engaged 
in high risk behavior. Interventions need to address basic social determinants and be 
culturally and developmentally appropriate for youth. While accessible health care for 
youth is clearly warranted, education and health promotion is needed throughout multiple 
social systems, which ideally would occur during early childhood psycho-social 
development. An inter-collaborative, multi-sectoral approach is needed to prevent youth 
from entering the street environment in the first place. 
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Appendix A:  Enhanced STD Surveillance In Canadian Street Youth Phase III 
Questionnaire- Female Version 
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Appendix B:  Algorithm For Saskatoon Street Youth Study Phase III 
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ALGORITHYM FOR STREET YOUTH STUDY PHASE III 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consent to to study participation: 
1. Protocol of study explained; Eligibility criteria met. 
2. Obtained 2 signed consents; 1 given to youth; other stored with 
questionnaire. 
3. Questionnaire administered.     
Consent to Blood Testing 
1. Blood collected as per consent. 
2. Specimen for Syphilis, anti-HBV, and 
HBV core antigen sent to Provincial lab. 
3. Specimen for HCV, HIV, HSV, and 
HTLV sent to St. Paul’s Hospital lab for 
centifuging prior to sending to Ottawa for 
testing and storage. 
Consent to Urine Testing 
1. Ask youth for first catch 
urine specimen.  
2. Specimen sent to 
Provincial lab. 
If Youth RETURNED for Results: 
Results for Chlamydia, Gonorrhea, Hepatitis B, 
Syphilis given. Youth given $10.00 honorarium. 
 IF all tests negative: No further action.  
 IF Ct and/or GC Positive: Treatment and 
counselling provided; contact information 
obtained; condoms given.   
 IF Hepatitis B core Positive: Follow up 
initiated. 
 IF Hepatitis B core and surface antibody 
negative: Referred for immunization. 
 
If Youth DOES NOT 
Return for Results 
 
1. No action taken unless 
positive for Ct, GC, 
HBV core, or Syphilis. 
 
2. If positive: contact 
tracing initiated for 
follow up and treatment.
Youth requested to return to site where they were 
tested in 2 weeks time for results: 
 Reminder card given to youth 
 Youth given $10.00 honorarium 
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Appendix C:  Location Of Saskatoon Recruitment Agencies 
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1. Bridges Alternative School 
20th Street 
 
2. Calder House 
2003 Arlington Avenue 
 
3. Egadz Downtown Youth Center 
301 1st Avenue North S7K 1X5 
 
4. Health Works van- Street Health Program-Public Health Services 
101-310 Idylwyld Drive N S7L 0Z2 
 
5. Safe House- Saskatoon Tribal Council  
526 Avenue S South 
 
6. Sexual Health Clinic- Sexual Health Program-Public Health Services 
101-310 Idylwyld Drive N S7L 0Z2 
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Appendix D:  Ethical Approval For Primary Research 
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Appendix E:  Consent For Research Participants 
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CONSENT  FORM 
 
Subject:  Enhanced STD Surveillance in Canadian Street Youth 
 
Investigators: Dr. C. Neudorf, Karen Grauer, Jocelyn Andrews, Maureen Laurie, 
Pamela de Bruin, Kathy Taylor, Colleen Charpentier, June Semple 
 
Contact Person: Jocelyn Andrews 
 
The purpose of this study is to explore issues in the lives of street youth that contribute to 
the risk of getting sexually transmitted infections, including HIV and to see what 
proportion of street youth are infected. 
 
You have been asked to take part in this study as a young person who spends much of 
your time in or around the streets.  The study involves taking part in a survey lasting 
thirty (30) to forty-five (45) minutes, giving a urine sample and two(2) tubes of blood 
from a single needle stick. Your part in the study will be kept confidential.  A study 
number, NOT your name, will appear on the survey and the urine and/or blood samples.   
 
It is possible that working through the survey with the nurse may bring up issues that are 
disturbing.  If so, please tell the nurse who will be able to help you.  You may freely 
refuse to answer any of the questions if you do not wish to disclose that information. 
 
Results to your tests (chlamydia, gonorrhea, hepatitis B and syphilis) will only be known 
to the study nurses and the laboratory. 
 
The urine will be tested for chlamydia and gonorrhea at the Provincial Laboratory.  If 
positive, one of the study nurses will treat you free of charge.  Treatment is simple: it 
involves taking four (4) or five (5) pills at one time.  This medicine is standard treatment 
for chlamydia and/or gonorrhea; it is not experimental treatment.  If you are positive, it 
will be necessary for your sexual partners to be treated also and that can be done without 
using your name.  
 
Your blood will be tested for hepatitis B and syphilis at the Provincial Laboratory.  If you 
are positive for these, the nurse will refer you for treatment for syphilis and for proper 
medical care for hepatitis B and a different consent will be obtained at that time- If you 
are positive for syphilis or hepatitis B, it will be necessary for your sexual partners to be 
notified. This can be done without using your name. The other blood tests will be done in 
Ottawa.  One tube of blood will be stored and frozen and may be tested at a later date for 
antibodies to herpes, hepatitis C,  HIV and HTLV.  These results are unlinked and we 
will NOT be able to give them to you.  If you would like to know your HIV and hepatitis 
C status, the nurse can arrange for you to be re-tested. 
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For taking the time to answer the survey, you will be given $10.00 at the end of the first 
visit and $10.00 when you come back for your results at the second visit.  If you answer 
the survey questions, but do not agree to the blood and/or urine sample, you can still get 
the $10.00. 
 
If you have any questions or want more information about this study or rights as a 
research subject, or if you experience any side effects or concerns about your treatment, 
you can contact Jocelyn Andrews at (306) 655-4620. 
 
Subject Statements: 
 
1. I understand that my part in this study is strictly voluntary and that I can refuse to 
take part or withdraw from the study at any time without any consequences to my 
continuing medical care. 
 
2. I have received a copy of this consent form for my own records. 
 
3. I consent to take part in this study provided the information I give is kept confidential. 
 
Name (please print): ______________________________________ 
 
Signature:  ______________________________________ 
 
 
Witness:  ______________________________________ 
  
 
Date:   ______________________________________ 
 
 
Notation: 
2 copies required: 1 for the participant and 1 for the Public Health Nurse study files. 
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Appendix F:  Letter Of Ethical Approval For Secondary Analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 142
 
 143
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Appendix G:  Personal Communication: Study Approval From Health Canada 
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Appendix H: Summary Multivariate Analysis 
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List of Abbreviations for Variables Analyzed 
 
Injection Drug Use Outcome:  
  
GENDER: 
 1 = male 
 2 = female 
 
DOB2: age 
 
FRSTNAT: 
 0 = Non- Aboriginal 
 1 = Aboriginal 
 
DISXPART: 
 1 = ≤ 7 lifetime sexual partners 
2 = Eight or more lifetime sexual partners 
 
TOTINJSX:  
0 = Sexual partners do not use injection drugs 
1 = Sexual partners that use injection drugs 
 
ALLSTW: 
0 = No history of sex trade work 
1 = History of sex trade work   
 
TOTABUSE: 
0 = Never sexually abused 
1 = Have been sexual abused 
 
PYSABUSE: 
  0 = Never physically abused  
1 = Have been physically abused 
 
EMABUSE: 
0 = Never emotionally abused 
1 = Have been emotionally abused 
 
DEPRESS2: 
0 = Not feeling depressed/hopeless 
 1 = Feeling depressed/hopeless 
 
SUICIDE2: 
0 = Never attempted suicide 
1 = Have attempted suicide 
 148
List of Abbreviations for Variables Analyzed (continued) 
 
NOTINSCH3: 
0 = Not attending school 
1 = Currently attending school 
 
LIVPAR2:  
0 = Not Living with parent/caregiver (daily) 
1 = Living with parents/caregiver (daily) 
 
SOCWRK: 
0 = Never had a social worker 
1 = Have had a social worker  
 
GRPHM: 
0 = Never lived in a group home 
1 = Have lived in a group home 
 
DPJE: 
0 = No history of incarceration 
1 = History of incarceration 
 
LVSTRT2: 
0 = Never lived on the streets 
1 = Have lived on the streets 
 
ABUSXGEN:  Sexual abuse history by gender 
 
ABUSXDOB:  Sexual abuse history by age 
 
STWXGEN:  Sex trade work history by gender 
 
STWXDOB:  Sex trade work history by age 
 
GRPHXGEN:  Group home history by gender 
 
GRPHXDOB:  Group home history by age 
 
LVSTXGEN:  Living on the street history by gender 
 
LVSTXDOB:  Living on the street history by age 
 
NOSCXGEN:  Not attending school by gender 
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Full Model of Injection Drug Use Outcome 
 
Variables in the Equation
-.143 1.149 .015 1 .901 .867 .091 8.249
.292 .195 2.253 1 .133 1.339 .915 1.962
.642 .747 .740 1 .390 1.901 .440 8.217
.340 .563 .364 1 .546 1.405 .466 4.235
2.578 .975 6.999 1 .008 13.175 1.951 88.988
4.944 5.135 .927 1 .336 140.294 .006 3296259
-1.151 5.998 .037 1 .848 .316 .000 40349.500
-2.039 1.722 1.402 1 .236 .130 .004 3.804
3.829 1.486 6.638 1 .010 46.022 2.500 847.245
.447 .576 .602 1 .438 1.564 .506 4.838
.874 .533 2.694 1 .101 2.397 .844 6.811
-.838 1.644 .260 1 .610 .432 .017 10.848
.801 .644 1.550 1 .213 2.228 .631 7.866
.180 .607 .088 1 .766 1.198 .365 3.932
-7.184 6.021 1.423 1 .233 .001 .000 101.232
1.826 .886 4.248 1 .039 6.209 1.094 35.242
-19.972 7.673 6.775 1 .009 .000 .000 .007
1.666 1.598 1.086 1 .297 5.290 .231 121.323
-.094 .250 .141 1 .707 .911 .558 1.485
3.647 1.407 6.722 1 .010 38.366 2.435 604.474
-.565 .255 4.908 1 .027 .568 .345 .937
.320 .286 1.255 1 .263 1.378 .786 2.413
.984 .354 7.714 1 .005 2.675 1.336 5.355
.216 1.244 .030 1 .862 1.241 .108 14.207
1.337 1.470 .828 1 .363 3.808 .214 67.891
-.018 1.089 .000 1 .987 .982 .116 8.294
-9.158 3.664 6.249 1 .012 .000
GENDER(1)
DOB2
FRSTNAT(1)
DISXPART(1)
TOTINJSX(1)
ALLSTW(1)
TOTABUSE(1)
PYSABUS2(1)
EMABUS2(1)
DEPRESS2(1)
SUICIDE2(1)
NOTINSC3(1)
LIVPAR2(1)
SOCWRK(1)
GRPHM(1)
DPJE(1)
LVSTRT2(1)
ABUSXGEN
ABUSXDOB
STWXGEN
STWXDOB
GRPHXDOB
LVSTXDOB
GRPHXGEN
LVSTXGEN
NOSCXGEN
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, FRSTNAT, DISXPART, TOTINJSX, ALLSTW, TOTABUSE, PYSABUS
EMABUS2, DEPRESS2, SUICIDE2, NOTINSC3, LIVPAR2, SOCWRK, GRPHM, DPJE, LVSTRT2, ABUSXGEN, ABUS
STWXGEN, STWXDOB, GRPHXDOB, LVSTXDOB, GRPHXGEN, LVSTXGEN, NOSCXGEN.
a. 
 
-2 Log Likelihood = 120.440, df = 26 
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Final Model of Injection Drug Use Outcome 
 
(Aboriginal ethnicity, categories of sexual lifetime partners, history of sexual and 
physical abuse, depression, not attending school, not living with parents/caregivers, 
social worker, group home, sexual abuse interactions, group home interactions, not 
attending school by gender, living on the street by gender excluded)  
 
Variables in the Equation
-.365 .708 .266 1 .606 .694 .173 2.782
.316 .128 6.106 1 .013 1.371 1.067 1.761
1.925 .779 6.103 1 .013 6.852 1.488 31.548
3.313 4.387 .570 1 .450 27.457 .005 148789.8
1.795 .938 3.663 1 .056 6.017 .958 37.796
.792 .480 2.718 1 .099 2.207 .861 5.655
1.924 .741 6.738 1 .009 6.845 1.602 29.253
-11.052 4.626 5.707 1 .017 .000 .000 .137
3.770 1.172 10.349 1 .001 43.392 4.363 431.547
-.464 .209 4.937 1 .026 .629 .417 .947
.582 .242 5.805 1 .016 1.790 1.115 2.875
-8.735 2.471 12.493 1 .000 .000
GENDER(1)
DOB2
TOTINJSX(1)
ALLSTW(1)
EMABUS2(1)
SUICIDE2(1)
DPJE(1)
LVSTRT2(1)
STWXGEN
STWXDOB
LVSTXDOB
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, TOTINJSX, ALLSTW, EMABUS2, SUICIDE2, DPJE, LVSTRT2,
STWXGEN, STWXDOB, LVSTXDOB.
a. 
 
 
-2 Log Likelihood = 135.137; df=11 
 
RM - FM = 135.137 - 120.440 = 14.697, ά =0.05 (calculated value < tabulated value, 
therefore model differences not significant)    
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List of Abbreviations for Variables Analyzed 
 
HCV Outcome: 
 
GENDER: 
 1 = male 
 2 = female  
 
DOB2: age 
 
DEPRESS2: 
0 = Not feeling depressed/hopeless 
 1 = Feeling depressed/hopeless 
 
SUICIDE2: 
0 = Never attempted suicide 
1 = Have attempted suicide 
 
ALLSTW: 
0 = No history of sex trade work 
1 = History of sex trade work   
 
UNCLEAN2: 
 0 = Use of clean equipment all of the time 
 1 = Use of unclean equipment 
 
PIERCE2: 
 0 = No ear and/or body piercing 
 1 = Has ear and/or body piercing 
 
FRSTINJ:  Age of first injection 
 
FINJXGEN:  Age of first injection by gender 
 
OFTDRK2: 
 0 = Alcohol use < once per week 
 1 = Alcohol use one or more times a week 
 
NOTINSCH3: 
0 = Not attending school 
1 = Currently attending school 
 
ALLABUSE: 
0 = Never sexually/emotionally/physically abused 
1 = Have been sexually and/or emotionally and/or phyically abused 
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List of Abbreviations for Variables Analyzed (continued) 
 
GRPHM: 
0 = Never lived in a group home 
1 = Have lived in a group home 
 
LIVPAR2:  
0 = Not Living with parent/caregiver (daily) 
1 = Living with parents/caregiver (daily) 
 
LVSTRT2: 
0 = Never lived on the streets 
1 = Have lived on the streets 
 
RITINJ2: 
 0 = Never used Ritalin by injection 
1 = Use of Ritalin by injection 
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Full Model for HCV Outcome 
 
 
Variables in the Equation
-19.768 11.206 3.112 1 .078 .000 .000 8.988
-.009 .211 .002 1 .967 .991 .655 1.500
.088 .897 .010 1 .922 1.092 .188 6.337
1.489 .947 2.471 1 .116 4.433 .693 28.375
-2.567 1.590 2.605 1 .107 .077 .003 1.734
.826 1.264 .428 1 .513 2.285 .192 27.204
.895 1.173 .582 1 .446 2.447 .246 24.384
-1.284 .905 2.016 1 .156 .277 .047 1.630
1.354 .721 3.523 1 .061 3.873 .942 15.928
-1.517 .977 2.411 1 .120 .219 .032 1.488
-.634 .993 .409 1 .523 .530 .076 3.711
.511 .892 .329 1 .566 1.667 .290 9.577
.504 .827 .371 1 .543 1.655 .327 8.379
.622 .949 .430 1 .512 1.863 .290 11.959
2.002 .988 4.107 1 .043 7.402 1.068 51.306
1.806 1.026 3.097 1 .078 6.083 .814 45.441
-6.171 6.040 1.044 1 .307 .002
GENDER(1)
DOB2
DEPRESS2(1
SUICIDE2(1)
ALLSTW(1)
UNCLEAN2(1
PIERCE2(1)
FRSTINJ
FINJXGEN
OFTDRK2(1)
NOTINSC3(1)
ALLABUSE(1)
GRPHM(1)
LIVPAR2(1)
LVSTRT2(1)
RITINJ2(1)
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, DEPRESS2, SUICIDE2, ALLSTW, UNCLEAN2, PIERCE2
FINJXGEN, OFTDRK2, NOTINSC3, ALLABUSE, GRPHM, LIVPAR2, LVSTRT2, RITINJ2.
a. 
 
 
-2 log likelihood = 54.829 
df = 16 
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Reduced Model: (Depression excluded)  
Variables in the Equation
-19.894 11.138 3.190 1 .074 .000 .000 6.928
-.009 .211 .002 1 .965 .991 .655 1.498
1.519 .899 2.853 1 .091 4.569 .784 26.629
-2.574 1.587 2.632 1 .105 .076 .003 1.709
.821 1.267 .420 1 .517 2.273 .190 27.216
.897 1.177 .581 1 .446 2.453 .244 24.631
-1.291 .902 2.046 1 .153 .275 .047 1.612
1.363 .717 3.616 1 .057 3.907 .959 15.915
-1.507 .972 2.406 1 .121 .221 .033 1.488
-.622 .983 .400 1 .527 .537 .078 3.688
.523 .882 .352 1 .553 1.688 .300 9.512
.515 .821 .394 1 .530 1.674 .335 8.360
.635 .942 .454 1 .500 1.887 .298 11.963
1.999 .988 4.096 1 .043 7.379 1.065 51.124
1.829 .998 3.358 1 .067 6.229 .881 44.057
-6.222 6.014 1.070 1 .301 .002
GENDER(1)
DOB2
SUICIDE2(1)
ALLSTW(1)
UNCLEAN2(1)
PIERCE2(1)
FRSTINJ
FINJXGEN
OFTDRK2(1)
NOTINSC3(1)
ALLABUSE(1)
GRPHM(1)
LIVPAR2(1)
LVSTRT2(1)
RITINJ2(1)
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, SUICIDE2, ALLSTW, UNCLEAN2, PIERCE2, FRSTINJ, FINJXGEN,
OFTDRK2, NOTINSC3, ALLABUSE, GRPHM, LIVPAR2, LVSTRT2, RITINJ2.
a. 
 
-2 log likelihood= 54.839; df= 15 
 
 
Reduced Model: (Depression, not attending school excluded) 
Variables in the Equation
-19.547 11.243 3.023 1 .082 .000 .000 12.049
.025 .199 .016 1 .900 1.025 .694 1.516
1.454 .876 2.758 1 .097 4.282 .769 23.834
-2.254 1.438 2.457 1 .117 .105 .006 1.758
.839 1.262 .442 1 .506 2.314 .195 27.470
.831 1.161 .512 1 .474 2.295 .236 22.347
-1.262 .903 1.952 1 .162 .283 .048 1.663
1.335 .720 3.434 1 .064 3.798 .926 15.580
-1.521 .976 2.429 1 .119 .218 .032 1.479
.461 .883 .273 1 .601 1.586 .281 8.945
.482 .815 .350 1 .554 1.619 .328 7.992
.582 .929 .392 1 .531 1.789 .290 11.054
1.978 .983 4.047 1 .044 7.228 1.052 49.648
1.991 .978 4.143 1 .042 7.324 1.077 49.821
-7.051 5.850 1.453 1 .228 .001
GENDER(1)
DOB2
SUICIDE2(1)
ALLSTW(1)
UNCLEAN2(1)
PIERCE2(1)
FRSTINJ
FINJXGEN
OFTDRK2(1)
ALLABUSE(1)
GRPHM(1)
LIVPAR2(1)
LVSTRT2(1)
RITINJ2(1)
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, SUICIDE2, ALLSTW, UNCLEAN2, PIERCE2, FRSTINJ, FINJXGEN,
OFTDRK2, ALLABUSE, GRPHM, LIVPAR2, LVSTRT2, RITINJ2.
a. 
 
-2 log likelihood = 55.243; df = 14 
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Reduced Model: (Depression, not attending school, lived in a group home excluded) 
Variables in the Equation
-20.319 11.830 2.950 1 .086 .000 .000 17.591
.018 .199 .008 1 .928 1.018 .690 1.502
1.496 .885 2.856 1 .091 4.462 .787 25.289
-2.106 1.419 2.203 1 .138 .122 .008 1.964
.769 1.233 .389 1 .533 2.157 .192 24.168
.915 1.139 .645 1 .422 2.496 .268 23.254
-1.286 .935 1.891 1 .169 .276 .044 1.727
1.380 .757 3.328 1 .068 3.975 .902 17.510
-1.592 .976 2.660 1 .103 .204 .030 1.378
.454 .873 .271 1 .603 1.575 .284 8.725
.462 .907 .259 1 .611 1.587 .268 9.389
2.009 .979 4.213 1 .040 7.459 1.095 50.821
2.071 .968 4.573 1 .032 7.934 1.189 52.945
-7.107 5.869 1.466 1 .226 .001
GENDER(1)
DOB2
SUICIDE2(1)
ALLSTW(1)
UNCLEAN2(1)
PIERCE2(1)
FRSTINJ
FINJXGEN
OFTDRK2(1)
ALLABUSE(1)
LIVPAR2(1)
LVSTRT2(1)
RITINJ2(1)
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, SUICIDE2, ALLSTW, UNCLEAN2, PIERCE2, FRSTINJ, FINJXGE
OFTDRK2, ALLABUSE, LIVPAR2, LVSTRT2, RITINJ2.
a. 
 
-2 log likelihood = 55.585; df = 13 
 
Final Model: 
 (Depression, not attending school, lived in a group home, regular use of alcohol 
excluded) 
Variables in the Equation
-19.636 10.784 3.315 1 .069 .000 .000 4.487
.056 .188 .088 1 .767 1.058 .731 1.530
1.586 .879 3.257 1 .071 4.886 .873 27.360
-2.507 1.412 3.152 1 .076 .082 .005 1.298
.590 1.161 .258 1 .612 1.803 .185 17.562
.623 1.017 .375 1 .540 1.864 .254 13.677
-1.305 .866 2.272 1 .132 .271 .050 1.480
1.350 .693 3.794 1 .051 3.858 .992 15.014
.869 .800 1.178 1 .278 2.383 .497 11.438
.739 .890 .689 1 .407 2.093 .366 11.977
1.873 .941 3.960 1 .047 6.509 1.029 41.188
1.845 .900 4.198 1 .040 6.326 1.083 36.943
-7.468 5.570 1.798 1 .180 .001
GENDER(1)
DOB2
SUICIDE2(1)
ALLSTW(1)
UNCLEAN2(1)
PIERCE2(1)
FRSTINJ
FINJXGEN
ALLABUSE(1)
LIVPAR2(1)
LVSTRT2(1)
RITINJ2(1)
Constant
Step
1
a
B S.E. Wald df Sig. Exp(B) Lower Upper
95.0% C.I.for EXP(B)
Variable(s) entered on step 1: GENDER, DOB2, SUICIDE2, ALLSTW, UNCLEAN2, PIERCE2, FRSTINJ, FINJXGE
ALLABUSE, LIVPAR2, LVSTRT2, RITINJ2.
a. 
 
-2 log likelihood = 58.792; df = 12 
RM- FM = 58.792 – 54.829 = 3.963, ά =0.05 (calculated value < tabulated value, 
therefore model differences not significant) 
